EP0848754A1 - Cloning methods for high strength spider silk proteins - Google Patents
Cloning methods for high strength spider silk proteinsInfo
- Publication number
- EP0848754A1 EP0848754A1 EP96932937A EP96932937A EP0848754A1 EP 0848754 A1 EP0848754 A1 EP 0848754A1 EP 96932937 A EP96932937 A EP 96932937A EP 96932937 A EP96932937 A EP 96932937A EP 0848754 A1 EP0848754 A1 EP 0848754A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dna
- silk
- protein
- spider
- primers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 249
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 220
- 238000000034 method Methods 0.000 title claims abstract description 135
- 229920001872 Spider silk Polymers 0.000 title claims abstract description 83
- 238000010367 cloning Methods 0.000 title abstract description 30
- 108020004414 DNA Proteins 0.000 claims abstract description 157
- 239000012634 fragment Substances 0.000 claims abstract description 49
- 241000239290 Araneae Species 0.000 claims abstract description 43
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 19
- 239000013615 primer Substances 0.000 claims description 74
- 230000008569 process Effects 0.000 claims description 46
- 108020001019 DNA Primers Proteins 0.000 claims description 35
- 239000003155 DNA primer Substances 0.000 claims description 35
- 239000002299 complementary DNA Substances 0.000 claims description 27
- 230000003252 repetitive effect Effects 0.000 claims description 25
- 239000013598 vector Substances 0.000 claims description 24
- 210000004027 cell Anatomy 0.000 claims description 22
- 239000000835 fiber Substances 0.000 claims description 22
- 108020004999 messenger RNA Proteins 0.000 claims description 21
- 241000255789 Bombyx mori Species 0.000 claims description 20
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 19
- 238000009987 spinning Methods 0.000 claims description 15
- 238000002604 ultrasonography Methods 0.000 claims description 12
- 239000004744 fabric Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000004202 carbamide Substances 0.000 claims description 10
- 230000000295 complement effect Effects 0.000 claims description 10
- 230000001915 proofreading effect Effects 0.000 claims description 10
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 claims description 9
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 claims description 9
- 241000238902 Nephila clavipes Species 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- 241000238903 Nephila Species 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 210000000170 cell membrane Anatomy 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 238000000108 ultra-filtration Methods 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 6
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 229910003002 lithium salt Inorganic materials 0.000 claims description 6
- 159000000002 lithium salts Chemical class 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 238000009396 hybridization Methods 0.000 claims description 5
- 229920000271 Kevlar® Polymers 0.000 claims description 4
- 241000335554 Mastophora <red algae> Species 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 4
- 229910002804 graphite Inorganic materials 0.000 claims description 4
- 239000010439 graphite Substances 0.000 claims description 4
- 239000004761 kevlar Substances 0.000 claims description 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 230000007928 solubilization Effects 0.000 claims description 4
- 238000005063 solubilization Methods 0.000 claims description 4
- 239000010936 titanium Substances 0.000 claims description 4
- 229910052719 titanium Inorganic materials 0.000 claims description 4
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 241001157788 Araneus Species 0.000 claims description 3
- 241000356504 Argiope Species 0.000 claims description 3
- 241001527647 Metepeira Species 0.000 claims description 3
- 241001516895 Micrathena Species 0.000 claims description 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 3
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 229960000789 guanidine hydrochloride Drugs 0.000 claims description 3
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 230000037452 priming Effects 0.000 claims description 3
- 238000013518 transcription Methods 0.000 claims description 3
- 230000035897 transcription Effects 0.000 claims description 3
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 2
- 108020003215 DNA Probes Proteins 0.000 claims description 2
- 239000003298 DNA probe Substances 0.000 claims description 2
- 241000023946 Gasteracantha Species 0.000 claims description 2
- DZHMRSPXDUUJER-UHFFFAOYSA-N [amino(hydroxy)methylidene]azanium;dihydrogen phosphate Chemical compound NC(N)=O.OP(O)(O)=O DZHMRSPXDUUJER-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000004917 carbon fiber Substances 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- -1 dichloroacetic aciα Substances 0.000 claims 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 194
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 21
- 238000000855 fermentation Methods 0.000 description 18
- 230000004151 fermentation Effects 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 18
- 230000014509 gene expression Effects 0.000 description 16
- 239000000872 buffer Substances 0.000 description 13
- 210000004907 gland Anatomy 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 108091005804 Peptidases Proteins 0.000 description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 12
- 239000004365 Protease Substances 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000006137 Luria-Bertani broth Substances 0.000 description 10
- 210000003743 erythrocyte Anatomy 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 238000012217 deletion Methods 0.000 description 9
- 230000037430 deletion Effects 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 8
- 229940041514 candida albicans extract Drugs 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- 230000035931 haemagglutination Effects 0.000 description 8
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 235000019419 proteases Nutrition 0.000 description 8
- 230000014616 translation Effects 0.000 description 8
- 239000012138 yeast extract Substances 0.000 description 8
- 108020004705 Codon Proteins 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 7
- 239000011324 bead Substances 0.000 description 7
- 238000012869 ethanol precipitation Methods 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 241000238901 Araneidae Species 0.000 description 6
- 102100034343 Integrase Human genes 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000011543 agarose gel Substances 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 241000713869 Moloney murine leukemia virus Species 0.000 description 5
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
- 108700005078 Synthetic Genes Proteins 0.000 description 5
- 108010006785 Taq Polymerase Proteins 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 239000012460 protein solution Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 239000004606 Fillers/Extenders Substances 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- 108091081024 Start codon Proteins 0.000 description 3
- 239000007984 Tris EDTA buffer Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000012411 cloning technique Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011592 zinc chloride Substances 0.000 description 3
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000239223 Arachnida Species 0.000 description 2
- 108010000241 Arthropod Proteins Proteins 0.000 description 2
- 108010023063 Bacto-peptone Proteins 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 238000009631 Broth culture Methods 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003398 denaturant Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108091005974 protein filaments Proteins 0.000 description 2
- 102000034272 protein filaments Human genes 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 108010028203 spidroin 2 Proteins 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241001280341 Araneoidea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000356536 Argiope bruennichi Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000501325 Embioptera Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 101000621107 Enterobacteria phage N4 Probable portal protein Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 240000007839 Kleinhovia hospita Species 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241001499227 Metepeira labyrinthea Species 0.000 description 1
- 241001607055 Micrathena sagittata Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000016941 Rho Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
- 108010053823 Rho Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000012410 cDNA cloning technique Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960004198 guanidine Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- OJTMBXWTXBFVQN-UHFFFAOYSA-N iron;1,10-phenanthroline Chemical compound [Fe].C1=CN=C2C3=NC=CC=C3C=CC2=C1 OJTMBXWTXBFVQN-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 238000007169 ligase reaction Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 108010054442 polyalanine Proteins 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 238000001799 protein solubilization Methods 0.000 description 1
- 230000007925 protein solubilization Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 108010028210 spidroin 1 Proteins 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- QHGNHLZPVBIIPX-UHFFFAOYSA-N tin(ii) oxide Chemical class [Sn]=O QHGNHLZPVBIIPX-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
Definitions
- This invention relates to novel methods of producing DNA fragments encoding for spider silk proteins.
- the present invention also relates to the DNA sequences encoding the spider silk proteins.
- This invention still further relates to novel methods of producing spider silk proteins using the above-described DNA sequences.
- the invention also relates to methods of purifying these spider silk proteins and manufacturing fibers and films from them.
- Nephila clavipes dragline silk was taken by Xu et al. (Proc. Natl. Acad. Sci. 87:7120, 1990) .
- Xu et al. ascertained a portion of the repetitive sequence of a spider dragline silk from a partial clone. Although this repeating unit encoded for up to 34 amino acids, it was not exactly conserved as the sequence had deletions and changes in some of the repeats. Nevertheless, Xu et al. discovered two important areas in the sequence -- repetitive regions which give spider silk some of their properties and a non-repetitive (carboxy) region. Hinman and Lewis (J: Biol. Chem.
- a second primer site is created at the unknown end of the DNA using a ligation cassette.
- a second primer site is created at the unknown end of the DNA using a terminal transferase to make a primer site selected from the group con ⁇ isting of poly dT, poly dA, poly dG and poly dC.
- This multimerizat. on process further comprises the steps of (iv) selecting a second pair of different DNA primers, at least one of the second pair of DNA primers being different than both of the sequences of the first pair of DNA primers, and at least one of the second pair of DNA primers being represented by the sequences (i) - (xxvi) ; (v) producing a second DNA fragment by repetitively combining the second pair of DNA primers with melted target DNA and incubating the combined DNA primers and target DNA with nucleotides and a DNA polymerase having proofreading ability to produce the second DNA fragment, the second DNA fragment being different than the first DNA fragment and also being complementary to the target DNA, the second DNA fragment being at least 2 Kb; (vi) restricting the first and ⁇ econd DNA fragment ⁇ ; and (vii) recombining the restricted portions of the first and second DNA fragments into a multimerized DNA, the multimerized DNA encoding spider silk protein and being at lea ⁇ t 4 Kb in length.
- primer sequences (i) - (xx) Some of the primers used are disclosed above as primer sequences (i) - (xx) . Although these primers were also tried by Beckwith & Arcidiacono, the present inventors are the first to produce spider silk protein up to 2 Kb in length using a two primer PCR cloning system. The present inventors were also able to produce spider silk proteins with higher Kbs by the claimed cDNA and ⁇ ingle site cloning methods de ⁇ cribed below.
- primer (iii) GCATGCACGCATGGTGCATGGATGC
- primer (ii) GGCGAATTCACCCTAGGGCTTGATAAACTGATTGAC primer (iii) was made from the peptide sequence 4 described by Mello et al. , Silk Polymers, ACS, Symposium, Ser 544 (1994) .
- Primer (ii) was made as described in Example 1 above.
- PCR mix 5 ⁇ l 10X Takara LA PCR buffer; 5 ⁇ l Takara dNTP mix; 1 ⁇ l primer (iii) (2 ⁇ M) ; 1 ⁇ l primer (ii) (2 ⁇ M) ; l ⁇ l Takara Ex Taq with proofreading activity; 1 ⁇ l spider genomic DNA; water to a total of 50 ⁇ l; and 50 ⁇ l mineral oil.
- the Takara LA PCR buffer, dNTP mix, and Takara Ex Taq were supplied with a Takara Roll kit distributed by Panvera Corp., 565 Science Dr., Madison, WI 53711. PCR cycler conditions were as follows: initial dwell 94°C.
- Positive transformant ⁇ were assayed for insertion by checking the size of insertion with a 1% agarose gel.
- the positive inserts were then tested for the correct insert by using PCR and poly d(T) 20 primer.
- the positives were also tested by the antibody methods discu ⁇ ed below.
- the positives passing the antibody tests for large mRNA were tested using SDS electrophoresis gels and found to give three different proteins also proving multiple start sites.
- One protein was slightly larger than the 2 Kb piece and the other two proteins were slightly shorter than native ⁇ pider silk dragline protein. It was difficult, however, to get these high molecular weight proteins to stain with a Western stain, but this was also true with the native proteins.
- the 2 Kb inserts were the longest spider silk pieces cloned. Because of this, it was theorized that a different technique would be required to make larger fragments. It was considered necessary that the technique obtain additional sequence information from parts of the protein coding towards the amino end because, with the available information from the protein sequencing, larger fragments were not produced. Although the 2 Kb piece was over 40% of full length, multimerization was considered necessary to increase strength characteristics -- as strength generally varies with the size of the ⁇ ilk polymer. Therefore, the inventors wanted to multimerize the 2 Kb insert to make a larger protein than the natural gene.
- Bacillu ⁇ expre ⁇ sion system ⁇ including Ex. subtilis sy ⁇ terns can also be used. These bacteria have the advantage of good secretion by the host, which results in less processing steps and processing costs. Although an expression cassette might be used, it has been found unneces ⁇ ary with the vector host system ⁇ studied thus far.
- One phagemid that can act as an EX . coli and Bacillus shuttle vector is pTZ18R which can be obtained from Pharmacia (Piscataway, NJ) .
- the purification of silk protein from the fermentation media can be accomplished by a two step process.
- the bacterial cells and precipitated protein can be removed by continuous centrifugation.
- the remaining material present in the fermentation broth can be separated by ultrafiltration since most of the protein above a molecular weight of 80,000 is silk.
- the protein silk streams from the continuous centrifugation and ultrafiltration procedures can then be combined.
- the bulk of the remaining proteins can be found in the bacterial membranes.
- By rupturing the bacterial cells using ultrasound the cells are opened and the ⁇ ilk protein in them i ⁇ removed.
Abstract
This invention relates to methods of producing DNA fragments encoding silk proteins from silk-producing spiders. The present invention also relates to the DNA sequences encoding the spider silk proteins. This invention still further relates to methods of producing spider silk proteins using the above-described DNA sequences. The methods of cloning and producing proteins of the present invention are applicable to all silk-producing spiders. Clones developed by these methods produce commercially useful quantities of high molecular weight silk proteins. Because the silk made from such proteins have superior strength properties, the cloned silk proteins of the present invention are of considerable industrial importance.
Description
TITLE
Cloninσ Methods For High Strength Spider Silk Proteins
Field of the Invention
This invention relates to novel methods of producing DNA fragments encoding for spider silk proteins. The present invention also relates to the DNA sequences encoding the spider silk proteins. This invention still further relates to novel methods of producing spider silk proteins using the above-described DNA sequences. The invention also relates to methods of purifying these spider silk proteins and manufacturing fibers and films from them.
Clones developed by the methods of the present invention produce commercially useful quantities of high molecular weight spider silk proteins ranging in molecular weights from 90,000 to over 250,000, which are from 40% to greater than 100% of the molecular weight of natural major ampulate (dragline) spider silk protein obtained from Nephila clavipes. Because the silk made from these high molecular weight proteins have superior physical properties, such as high tensile strength and substantial elasticity, the cloned silk proteins of the present invention are of considerable industrial importance.
These spider silk proteins have been cloned by several methods of the present invention and the natural sequence spider silk clones have been produced in E. coli expression systems. These expression systems have then been used to produce various partial and full length natural spider silk proteins, which have been expressed at levels in excess of 2 grams per liter of cell mass. These spider silk proteins are then purified and used for many purposes such aε spinning fibers, forming films and other applications resulting from the weaving of filaments.
Background of the Invention
Silk production by many diverse animal orders (e.g.. insects, arachnids and mites) iε well known. Spiders, for example, produce natural webs and draglines having high tensile strengths. Silkworms, on the other hand, although producing silks at high production rates, have silk proteins that are considered inferior to spider silk proteins in their physical properties. For example, silkworm proteins have considerably lower tensile strengths than spider silk proteins. Orb weavers and other spiders, although naturally producing low quantities of silk filaments (less than economic for commercialization), have strong filaments. In fact, spider filaments can be several times stronger than Kevlar* (9.5 x IO4 vs 3 x IO4 Jkg"1) . These superior strength properties make spider silk protein filaments a preferred choice for parachutes, sails, body armor and other high strength applications requiring strong filaments. Additionally, these spider filaments find utility as absorbent films for many heavy metals and organics including biological weapons. They also find utility as absorbents that selectively bind DNA and absorbents for many other chemicals, flavors and fragrances.
Although it might be hypothesized that spider silk could be produced from culturing spiders, this is impractical for several reasons. First, in addition to being very difficult to raise, spiders will eat their neighbors if grown in very high densities. Second, spiders produce only small amounts of silk protein making production of even milligram quantities prohibitively expensive. As a result of these limitations, the only acceptable method for producing commercial quantities of spider silk proteins is to clone the spider gene into an acceptable large scale production vector. The present invention accomplishes that objective.
Synthetic silk protein genes have previously been produced by making short base pair segments and then using large numbers of repeating unitε. Proteins with modest molecular weights (ranging from 20,000 to 80,000) have been obtained by such a process. To achieve a variety of physical properties, this process has been varied and synthetic proteins with different sequences have been produced. For example, prior workers have used sequences obtained by taking small lengths of naturally occurring silk proteins and changing the sequences.
These prior methods, however, have resulted in materials that are inferior to natural silks.
Moreover, in some cases, this prior technology has also produced clones that are unstable for the long term use required for commercial applications. Therefore, one of tne objects of the present invention is to overcome the above-mentioned problems that occur with polymerized short DNA sequences. This is accomplished with the present invention by the production of long DNA that encode for high strength, high molecular weight silk proteins.
Because of the potential that high strength ma^or ampulate (dragline) spider silk offers, silks from orb weavers such as Nephila clavipes have been studied in attempts to understand the molecular basis of their strength. Researchers have also attempted with limited success to clone the natural protein or make a synthetic silk gene by incorporating the repetitive elements responsible for the high strength of spider silk fibers.
There are, however, many problems associated with cloning a silk protein. First, the natural protein amino acid sequence is composed of numerous repeating subunits, and therefore dees not have many unique sites that can be used to clone the natural gene. The literature indicates that the carboxy end of dragline spider silk protein from Nephila clavipes iε the only area shown to be unique. This has lead to only a few prior attempts at cloning the natural gene, and consequently many more prior attempts at making a synthetic protein. Nevertheless, making stable clones and the resultant synthetic spider silk proteins are replete with problems owing to the repetitiveness of the DNA sequence that is being mimicked. For example, DNA with high amounts of repeats (especially GCA repeats) is unstable due to transcription errors and the high probability of recombinational deletions, resulting in constantly changing DNA. Because of these problems, the integrity of many clones has been questionable.
In nature, silk genes are quite stable oecause of the intermixing of repetitive and non-repetitive regions. Unfortunately, synthetic genes do not lend themselves to such constructions as they are highly unstable to recombination and recombinational deletions in particular. Failure to obtain stable clones has
occurred because insufficient amounts of the gene were cloned and therefore the non-repetitive regions that possibly form the basis of their natural stability were not obtained. It is therefore one of the objects of the present invention to obtain stable clones having non-repetitive as well as repetitive regions.
Another problem with cloning dragline spider silk is the size of the gene. Spider silk proteins typically are 200,000 kDa or higher and the corresponding genes also have at least one intron. As such, it iε projected that the size of the DNA fragment would be in the range of 5-10 Kb plus any introns. With current technology, genes of this magnitude are still notoriously difficult to clone. The present invention has overcome this problem.
Because of their mechanical strength properties, much attention has been directed to the cloning of spider silk proteins. A major advance in understanding
Nephila clavipes dragline silk was taken by Xu et al. (Proc. Natl. Acad. Sci. 87:7120, 1990) . Xu et al. ascertained a portion of the repetitive sequence of a spider dragline silk from a partial clone. Although this repeating unit encoded for up to 34 amino acids, it was not exactly conserved as the sequence had deletions and changes in some of the repeats. Nevertheless, Xu et al. discovered two important areas in the sequence -- repetitive regions which give spider silk some of their properties and a non-repetitive (carboxy) region. Hinman and Lewis (J: Biol. Chem. 257:13320, 1992) reported a second cDNA clone presumed to be from a second spider protein. This sequence had a similar repetitive region as that discovered by Xu et al. and a carboxy terminal non-repetitive end. The Hinman and Lewis repeating unit was longer, encoding for 51 amino acids, and highly variable.
In the expression of spider silk proteins by Lewis et al. , European Patent Application EP 0452925 A2, published 10/23/91, only small protein fragments were apparently produced in small yields. These small protein fragments are probably of no commercial value because good mechanical properties only result from larger proteins, especially those close to full length. Lombardi et al., International Patent Application WO 91/16351, published 10/31/91, also produced a recombinant spider silk protein in very low yields, but these clones appeared to have low mechanical strength due to their small molecular weights.
It is also theorized that the spider silk clones heretofore developed do not represent faithful copies of the natural gene. This is confirmed by a number of studieε, for example, Beckwith & Arcidiacono (J. Biol. Chem. 269(9):6661, 1994) εhowing that both spider proteins have a high homology and may in fact represent the same protein.
Although many researchers have conceded that natural expression systems are useful as silk variants, they have been unable to overcome the expression problems based upon codon preferences. While it is believed that using highly conserved repetitious repeat regions can produce improved proteins, these synthetic gene expression systemε εuffer from DNA stability problems, low expression rates, and the production of proteins with less desirable properties than those of natural spider silk. It is therefore an object of the present invention to overcome these problems.
Ferrari et al., International Patent Application WO 88/03533, published 5/19/88, disclosed synthetic genes which produced protein with silk-like properties. In addition, a number of small repeat proteins mimicking
natural fiber proteinε were developed by Cappello et al., International Patent Application WO 90/05177, published 5/17/90. Floyd, International Patent Application WO 94/29450, published 12/22/94, also attempted to develop a spider silk synthetic gene using a number of natural repeat units developed by Xu et ai. All of these clones, however, have small molecular weights that preclude them from having the desired properties of natural spider silk.
The present invention relates to the novel synthesis of partial and full length spider silk protein clones. Some of these partial length clones have also been multimerized into other clones with molecular weights up to and exceeding those of natural spider silk. The present invention has made it possible to develop natural silk-like clones that have a complete range of properties. One skilled in molecular biology can use these clones as a starting point for creating clones with other useful silk properties such as strength, yield point, adhesiveness and plasticity. Furthermore, these new sequences can be used as starting points to design other synthetic genes. For some spiders which incorporate colors or pigments into their silk proteins, these methods may also permit naturally colored protein.
The present invention also relates to unique chemical methods for fermentation of transfected hosts in culture media. One of the major problems of producing silk proteins by bacterial fermentations is the partial ύiytotlon of proteins by proteases. In fact, the rate of protein decomposition from proteases can in some cases overcome the rate of high molecular weight silk protein expression, thereby making commercial operations impractical. The present invention overcomes this potential problem.
These and additional objects and advantages of the present invention are shown from the descriptions below.
Brief Deεcription of the Figure
Figure 1 shows the 2Kb DNA sequence for encoding the spider silk protein.
Summary of the Invention
This invention relates to a procesε of producing DNA fragmentε encoding for silk protein, comprising the stepε of (i) selecting target DNA harvested from a silk-producing spider, the target DNA comprising a plurality of repetitive and non-repetitive regions; (ii) selecting a single strand DNA primer of at least 10 nucleotides having a DNA sequence that is complementary to a region in the target DNA; and (iii) repetitively combining the DNA primer with melted target DNA and incubating the combined DNA primer and target DNA with nucleotides and a DNA polymerase having proofreading ability to produce the DNA fragment, wherein the DNA fragment iε complementary to said target DNA and is at least 2 Kb. In a more particular embodiment, DNA fragments of at least 5 Kb can be produced.
In a further embodiment of the above-described process of producing a DNA fragment encoding silk protein, the process comprises the step of using two different DNA primers instead υl out. In still further embodiments of the processes for producing a DNA fragment using a single strand DNA primer or two different DNA primers, the target DNA is cDNA made by reverse transcription of full length mRNA coding for spider silk, and the procesε further comprises the steps of (i) adding a
primer site to the amino terminal end of the first strand cDNA made thereof and (ii) using the poly T region of the cDNA aε a firεt polymeraεe priming region. In a still further embodiment of these processes for producing a DNA fragment, a second primer site is created at the unknown end of the DNA using a ligation cassette. In a still further embodiment, a second primer site is created at the unknown end of the DNA using a terminal transferase to make a primer site selected from the group conεisting of poly dT, poly dA, poly dG and poly dC.
The DNA primer for the above-described processeε of producing a DNA fragment can be εelected from DNA repreεented by εtarting and ending sequences (i) - (xx) given below:
GGCGAATTCGGATCCATGGCAGCAGCAGCAGCAGCAGCT;
(ii) GGCGAATTCACCCTGGGCTTGATAAACTGATTGAC; (iii) GCATGCACGCATGGTGCATGGATGC;
(iv) TTCGAATTCATGGGCCCTGGACAACAAGGACCATCTGGACCT;
(v) GGAAGGCGGGCAGTGAGCGCAACGCAATTAATG;
(vi) GAYGAYGGNAAYGCNGT;
(vii) TGNTGNCCSGTTCG; (viii) CGSCGKCGSCCACGSCCSCG;
(ix) GTTAAATGTAAAATCAAGAGTTGCTAA;
(x) GGCCAATCTCTTTTGAGTGCATTTTAA;
(xi) TAAGCAACTCTTGATTTTACATTTAAC;
(xii) TTAAAATGCACTCAAAAGAGATTGGCC; (xiii) TCAGCAGAATCTGGACAACAAGGCCCA; r.iv) CCNCGNCCN TYCC,
( v) GGTGCAGCAGCAGCAGCTGCWGG;
( vi) GGTGGTGCCGGACAAGGAGG TATGGAGGWCTTGGA;
( vii) GGWGGACGAGGTGGATTA; (xviii) GATAAAAAGAAATATGCTGCAGAACTTCACTTGGTTCAC;
(xix) CARGCNGGNGCNGCNGSNGGNGGNTTYGGNCC; and
( x) GGNGGNGGNGCNGGNCARGCNGGNGCNGCNGSNGGNGGNTTYG GNCCNGGNGCNGGNGGN,
wherein N = G, A, T, C; V = G, A, C; B = G, T, C; H = A, T, C; D = G, A, T; K = G, T; S = G, C; W = A, T; M = A, C; Y = C, T; and R = A, G.
In a still further embodiment of the processes for producing a DNA fragment, the target DNA is selected by hybridization to a DNA probe, having at least one of the above-described sequences (i) - (xx) , that is reversibly bound to a support to enrich for the silk- encoding DNA fragments.
In another process embodiment of producing a DNA fragment encoding εilk protein, called the multimerization proceεs, the process comprises the steps of (i) selecting a target DNA encoding silk protein harvested from a silk-producing spider, the target DNA comprising a plurality of repetitive and non-repetitive regions; (ii) selecting a first pair of different DNA primers, the first pair of DNA primers both being complementary to a region in the target DNA, and at least one of the first pair of DNA primers being represented by the sequences (i) - (xxvi) ; (iii) producing a first DNA fragment by repetitively combining the first pair of DNA primers with melted target DNA and incubating the combined DNA primers and target DNA with nucleotides and a DNA polymerase having proofreading ability to produce the first DNA fragment, the first DNA fragment being complementary to the target DNA and at least 2 Kb. This multimerizat. on process further comprises the steps of (iv) selecting a second pair of different DNA primers, at least one of the second pair of DNA primers being different than both of the sequences of the first pair of DNA primers, and at least one of the second pair of DNA primers being represented by the sequences (i) - (xxvi) ; (v)
producing a second DNA fragment by repetitively combining the second pair of DNA primers with melted target DNA and incubating the combined DNA primers and target DNA with nucleotides and a DNA polymerase having proofreading ability to produce the second DNA fragment, the second DNA fragment being different than the first DNA fragment and also being complementary to the target DNA, the second DNA fragment being at least 2 Kb; (vi) restricting the first and εecond DNA fragmentε; and (vii) recombining the restricted portions of the first and second DNA fragments into a multimerized DNA, the multimerized DNA encoding spider silk protein and being at leaεt 4 Kb in length.
In a more particular embodiment of the above-deεcribed multimerization proceεs, all DNA primers are represented by εequenceε (i) - (xxvi) . In another particular multimerization proceεε embodiment, all DNA primerε are different. In a still more particular multimerization process embodiment, the multimerized DNA is at least 6 Kb or 8 Kb in length.
In a DNA sequence embodiment, thiε invention relateε to a DNA sequence encoding spider silk protein, wherein the DNA sequence compriseε a plurality of repetitive and non-repetitive regionε and has a length of at least 2 Kb. In a more particular embodiment, the DNA sequence has a length of at least 5 Kb. In a still more particular DNA sequence embodiment of the present invention, the DNA comprises the sequence illustrated in Figure 1.
In a process of producing silk protein embodiment, this invention comprises the stepε of (i) εelecting a DNA; (ii) inserting the DNA into an expresεion vector; (iii) transfecting host cells with the expression vector; (iv) fermenting the transfected host in culture media
to produce silk protein; and (v) recovering the silk protein. In a more particular silk protein production process embodiment, the culture media for fermenting the transfected host contains protease inhibitor. In a still further silk protein production process embodiment, the process compriseε the steps of (i) applying ultrasound energy to rupture the host cells; (ii) applying ultrasound energy to resuspend the silk protein; and (iii) centrifuging the ruptured host cellε to separate cell membranes from the silk protein. In theεe εilk protein production proceεεes, purification of the silk protein is accomplished by ultrafiltration or alcohol precipitation.
In a process for spinning silk protein embodiment, this invention relates to a process comprising the steps of (i) concentrating silk protein purified by ultrafiltration or alcohol precipitation; (ii) drawing a fiber of concentrated silk protein; (iii) spinning silk fibers to produce a εilk thread; and (iv) washing the silk thread to remove any solubilization reagents. The solubilization reagents are selected from the group consisting of hexafluoroisopropanol, sodium hydroxide, potassium hydroxide, urea, urea phosphate, lithium salts, organic solvents, guanidine nydrochloride, ammonium sulfate, acetic acid, phosphoric acid, dichloroacetic acid, formic acid and sulfuric acid. In a still more particular process of spinning εilk, the process further compriseε the εtep of coating the silk fiber or thread with oxides of tin or titanium.
In a faoilc embodiment., the present invention relates to a fabric comprising the spider silk threads made according to any of the processes of the invention. In a further fabric embodiment, the fabric comprises spider silk threads made in accordance with any of the processes of the present invention in combination with
Kevlar®, graphite or carbon fibers, as well as silkworm silk.
The protein can be used aε a coating, extruded into a fiber, or made into a polymeric film.
Detailed Deεcription of the Invention
Sources of Silk-Producing Spider DNA
While the methods of the preεent invention were εpecifically developed to clone Nephila clavipeε major ampulate (dragline) spider silk, the methodε of cloning and producing εilk proteins are applicable to all silk- producing εpiders.
As a group, spiders may have up to eight kinds of silk glands. Although no spider species has all eight silk glands, all spiders have at leaεt three such glands and most have five. Each gland produces a different type of silk having different properties. For example, some silk dries quickly, while other silk remains sticky.
Spiders belong to the phylum Arthropoda. class Arachnida and order Araneae. True spiders belong to the suborder Labidognatha. Other spider types include comb footed, crab, fisher, funnel web, hackled-band, orb weavers, jumping and ogre faced stick. Spiders from any of the following genus groups can be used in accordance with the present invention: Micrathena. Mastophora. Metepeira, Araneus, Argiope. Nephila or Gas eraca L a.
Orb weaverε are among the moεt successful spider groups because they have evolved silkε with remarkable εtrength and flexibility. The orb weaverε are known aε Argionidae and include: arrowheaded shaped Micrathena
sagittata. bolas spider Mastophora cornigera, labyrinth Metepeira labyrinthea, marbled Araneuε marmoreuε. black-and-yellow garden Argiope bruennichi. golden silk Nephila clavipes. and spiny bodied Gasteracantha cancrifσrmis.
Nephila clavipeε has been studied the most in genetic research since its silk threadε are strong and its silk glands are large and easy to dissect. Other orb weavers also produce strong silk threads.
While all spiders produce silk, the proteins that form the silk threads vary considerably in their molecular makeup and serve a variety of purposes. For example, the Antrodiatus εpiders spin a simple kind of silk comprising just two proteins. In contrast, spiders in the family Araneoidea, called web spinners, produce up to eight different kinds of silk. Orb weavers produce a variety of silks using several proteins to create webs of greater εtrength and flexibility.
Spider εilk proteins also have different qualitieε depending upon which silk gland it was spun from. The strongeεt silks known are from the major ampulate gland of orb weavers. Of the eight types of silk produced by orb spiders, the major ampulate (dragline) silk was selected for this work because of its physical strength and non-sticky properties. This dragline silk is composed of protein although carbohydrates are associated with the fiber. In the spider's spinneret, the liquid silk undergoes an irreversible transition to an insoluble lorm composed OJ. a nigh relative ratio of alanine and glycine. This fiber consists of an antiparallel /3-sheet with elastic interspaces. The amino acid compoεition of this silk (shown in the table below) mimics the composition of clones of the present invention.
Percent Amino Acid Compoεition Of Nephila clavipeε Major Ampulate Spider Silk
Amino Acid Protein 220 kDa Band 190 kDa Band glutamic acid 8.52 9.77 9.35 εerine 3.51 2.57 2.79 glycine 41.66 45.88 44.80 arginine 1.28. 1.98 2.28 alanine 25.25 28.57 28.35 proline 0.78 0.37 0.51 tyroεine' 4.20 3.25 3.26 leucine 4.82 4.62 4.48
Silk Polymers, ACS, Sympoεium, Ser. 544, 1994.
Cloning
Two Primer PCR Cloning
Although many researches have tried cloning repetitive silk genes using PCR-type techniques, at leaεt two problemε have occurred. Theεe PCR techniqueε could not tranεcribe DNA with good fidelity for a gene that waε 8-15 Kb in length. In fact, moεt clones reported in the literature have been transcribed incorrectly.
Therefore, the present inventors εet out to overcome theεe shortcomings and found that by using somewhat degenerate primerε either one or a number of PCR products could be produced.
Genomic DNA taken from Nephila clavipeε abdomenε was used. To isolate the DNA from the spider, the preparation method described in Sambrook et al. , Molecular Cloning: A Laboratory Manual, Vol.1-3, Cold Spring Harbor Laboratory, New York (1989) , was followed exactly. This procedure resulted in high molecular weight genomic DNA in excess of 2 Kb.
The inventors experimented with many primers that were related to the εequence data disclosed by Xu et al.
Some of the primers used are disclosed above as primer
sequences (i) - (xx) . Although these primers were also tried by Beckwith & Arcidiacono, the present inventors are the first to produce spider silk protein up to 2 Kb in length using a two primer PCR cloning system. The present inventors were also able to produce spider silk proteins with higher Kbs by the claimed cDNA and εingle site cloning methods deεcribed below.
Initial conditionε for PCR cloneε were produced using primers derived from spidroin 1 as defined by Xu et al. and Hinman and Lewis. Using normal PCR with Taq polymerase (Stratagene product no. 600131 under license from Perkin Elmer, Stratagene, 11011 North Torrey Pines Road, La Jolla, CA) , the inventors could only get PCR products of up to 700-1000 bp, which supportε the findings of otherε. Even theεe small pieces were considered of dubious quality. Using a Taq extender (Stratagene product no. 600148) , a number of bands of up to about 1900 bp were obtained as εhown in Example 1. However, when another polymeraεe with proofreading activity waε uεed (Takara Taq LA) , only one primary band waε obtained as described in Example 2 below.
Example 1: Cloning with Taq polymerase
In this example, Nephila clavipes DNA isolated by the procedure of Beckwith & Arcidiacono was used along with the following two primers: primers (i) GGCGAATTCGGATCCATGGCAGCAGCAGCAGCAGCAGCT, and (ii) GGCGAATTCACCCTAGGGCTTGATAAACTGATTGAC.
Primer (i) codes for a poly-alanine repeat sequence based on che forward reading frame. Leader sequences that insert an in-frame start codon and both BamH I and EcoR I leader restriction sites for cloning as overhangs were also put into the primer. Primer (ii) is a PCR primer (bp 2218 to 2242) based upon the reverse sequence of Xu et al. This sequence also has
an in frame stop codon and an EcoR I restriction site. As shown in this Example and Example 2, the reεults depend on the PCR conditions and are not positive without newer polymerases. The regular Taq and the Taq extender did not give the same results, presumably due to misreading or false priming.
The PCR mix was as follows: 5 μl Taq extender buffer (Stratagene) ; 1 μl of Taq polymerase 5 μg/μl (Stratagene) ; 1 μl of lμg/μl DNA template (spider genomic DNA) ; 1 μl of 2 μM primer (i) in water; 1 μl of 2 μM primer (ii) in water; 5 μl of NTP's (2 μM each of dATP, dCTP, dGTP, and dTTP, pH 7.0); 45 μl of Taq extender (Stratagene) ; and water to a total of 100 μl total.
The PCR cycler conditions were as follows: initial dwell 94°C. for 2 min; and PCR conditions (30 cycles) : annealing at 60°C. for 1 min.; extension at 72°C. for 2 min.; and denaturation at 94°C. for 1 min.
Alternatively, the PCR conditions of annealing at 60°C. for l min. and extension at 72°C. for 2 min. can be replaced with a treatment of 72°C. for 2 min.
A 5μl portion of this reaction mixture analyzed by 1% agarose electrophoresis showed DNA bands. With this technique, up to 7 DNA bands were achieved which were asεumed to represent a number of alanine repeat regions in the sequence. The largest DNA fragment was 1900-2000 bp (and waε referred to aε a 2 Kb piece) . Thiε iε eεsentially the same band as achieved in Exam l 2. This was cut out of the gel with Gene Capsule™ (Cat. No. 786-001 from Geno Technology Inc., 3830 Washington Blvd., St. Louis, MO 63108), purified with phenol and ethanol precipitation. These bandε were cloned into EX. coli XLl MRF' super-competent cells using the procedure described in Example 2 below. The
2 Kb piece was also found when the Takara Ex Taq LA polymerase PCR conditions described in Example 2 were used with primers (ii) and (iii) .
Example 2: Cloning with Takara Tag LA polymerase
The genomic DNA was isolated from freeze dried spider abdomens which were ground in a mortar and pestal and extracted according to Sambrook et al. , Molecular Cloning: A Laboratory Manual Vol. 1-3, Cold Spring Harbor Laboratory, New York (1989) .
The cloning for this Example was accomplished with the following primers: primer (iii) GCATGCACGCATGGTGCATGGATGC, and primer (ii) GGCGAATTCACCCTAGGGCTTGATAAACTGATTGAC. Primer (iii) was made from the peptide sequence 4 described by Mello et al. , Silk Polymers, ACS, Symposium, Ser 544 (1994) . Primer (ii) was made as described in Example 1 above.
The following PCR mix and conditions were used. PCR mix: 5 μl 10X Takara LA PCR buffer; 5 μl Takara dNTP mix; 1 μl primer (iii) (2 μM) ; 1 μl primer (ii) (2 μM) ; l μl Takara Ex Taq with proofreading activity; 1 μl spider genomic DNA; water to a total of 50 μl; and 50 μl mineral oil. The Takara LA PCR buffer, dNTP mix, and Takara Ex Taq were supplied with a Takara Roll kit distributed by Panvera Corp., 565 Science Dr., Madison, WI 53711. PCR cycler conditions were as follows: initial dwell 94°C. for l min.; PCR conditions (30 cycles) : annealing ana extension at 68°C. for l min. and denaturation at 94°C. for 1 min.; and post dwell at 4°C.
To inεert thiε 2 Kb piece into EX. coli. a familiar vector, pUC18, waε chosen because the plaεmid had a good number of cloning siteε and could express proteins well. It is also known that this vector is suited to sequence analysis using well known primers. To insert thiε 2 Kb piece into EX. coli XLl MRF', pUC18 was first prepared in a 1 μg/μl DNA preparation obtained from Sigma Chemical Co., P.O. Box 14508, St. Louis, MO 63178-9916. Restriction enzymes were also εimilarly uεed to digeεt the insert. The restriction protocol was as follows: 5 μg or less of plasmid or insert DNA; 5 μl of restriction enzyme 10X buffer; 5 μl 1 mg/ml acetylated BSA; 5 μl restriction enzyme (EcoR I) ; water to a final volume of 50 μl; and incubate for 3 hr. at 37°C.
The vector was also treated after phenol extraction and cleanup with EcoR I restriction enzyme. The vector was similarly treated with calf intestinal alkaline phosphatase (CIAP) . This treatment prevented the vector from re-annealing.
The CIAP protocol, which was done in addition to the restriction protocol, was as follows: 10 μl CIAP 10X buffer consiεting of 500 mM triε-HCl, pH 9.0, 10 mM MgCl2, 1 mM ZnCl2 and 10 mM spermidine; 1 unit CIAP; water to final volume of 100 μl; and incubate for 60 min. at 37°C. One CIAP unit will hydrolyze 6.0 mM of p-nitrophenyl phosphate per minute at 37°C. These units are measured in a 0.1 M glycine buffer at pH 10.4 containing 1.0 mM ZnCl2, 1.0 M MgCl2. The next step was to ligate the insert into the pUC18. To do this, the DNA was repurified with phenol extraction and ethanol precipitation and then ligated according to the protocol described below.
Ligation protocol: 100 ng vector DNA; 100 ng or less insert DNA; l unit T4 DNA ligase (Weiss Units) ; l μl ligase 10X buffer; water to a final volume cf 10 μl; and incubate for 1 hr. at room temperature.
The new vector was then inserted into EX. coli XLl MRF' obtained from Clonetech Laboratories, Inc., 4030 Fabian Way, Palo Alto, CA 94303, using the Clonetech method for inserting supercompetent cells. The transformants were selected by ampicillin resistance in LB broth 10 g/1 bactopeptone, 5 g/1 yeast extract, and 5 g/1 NaCl using 50 μg/μl of ampicillin. Clones were checked for the proper insert by first looking for the proper size of plasmid, approximately 4.3 Kb. The insert was also checked by using biotinylated probes and asεaying for hybridization. The beεt 5 inserts from transformation were checked for expression of the inserted protein as it was inserted in such a way that it should express within pUC18.
The 2 Kb insert was easily made using the PCR technique described above. This technique produced superior results over the following three methods: screening of shotgun clone libraries for silk by probes based upon peptide sequencing (Xu et al.); cDNA inserts from the silk gland (Hinman and Lewis) ; and PCR using Taq polymerase or other polymerases with no proof reading. (Beckwith and Arcidiacono) .
The PCR technique of Example 2 compared to the above three methods was faεt, did not induce errorε into the sequence as was apparent from the other reported methods, and was directed only to the gene of interest. With just a little of the sequence from the amino end and carboxy end of the spider silk, this technique could be applied to the sequencing of silks other than
the major ampulate (dragline) silk or to other spiders having similar properties.
To determine whether the protein was expressing in the EX. coli host, antibody assayε were developed for the determination of spider silk protein. These antibody asεayε are diεcuεεed below. In addition, SDS gel electrophoreεis, indicated that the 2 Kb insert was producing a 94 kDa protein in good yield. The gel electrophoresis was done according to the procedure of Mellow et al., Silk Polymers, ACS, Symposium Ser. 544 (1994). Uεing LB broth, the yields ranged from 0.1-10% of the total protein produced by the bacteria. Western blotting using BioRad Kit #170-6460 from Bio-Rad Laboratories, 3300 Regatta Blvd., Richmond, CA 94804, also confirmed that this protein was a silk protein, and it was the only protein showing antibody reaction.
This 2 Kb insert, as well as the other inserts developed by the present inventors, were sequenced according to normal conditions using the Promega silver sequence syεtem, Cat. No. Q4130 Promega Corporation, 2800 Woodε Hollow Rd., Madiεon, WI 53711-5399. Thiε waε done by uεing multiple primerε, deletion clones and other cloneε based upon Example 1. Thiε sequence has been characterized by the DNA and protein sequence shown in Figure 1.
Cloning from cDNA
Many researchers have attempted to clone Nephila clavipes spider silk with little success as only small pieces have ever been cloned. The problems asεociated with cloning from cDNA have included the inability to obtain full length mRNA, poor reverse transcription of the protein and poor fidelity. Another major problem has been the inability to obtain satisfactory amounts
of mDNA from the silk glands. The cDNA cloning technique of the present invention, which is described below, overcomes these problems.
Example 3
A. Development of full length mRNA
Before this cloning technique could be successful, the problem of obtaining full length mRNA had to be resolved. Since the copy number of mRNA in the εilk gland of εpiders is extremely low, it was decided to use the silkworm Bombyx mori in order to develop an analogous method of obtaining full length mRNA from spider silk glands. It was discovered after numerous mRΝA isolation methods were tried, that a mRNA purification kit (# 8-MB4003K) from PerSeptive Diagnosticε (Cambridge, MA) could consistently separate essentially full length mRNA without any appreciable degradation. This mRNA purification technique uses biomagnetic bead separation and oligo (dT)20 particles to separate the mRΝA.
B. Development of a long and accurate PCR technique
The next step in the development process was to convert the mRΝA to a good first strand template and then reliably replicate the DΝA. Using an Invitrogen Cycle mRΝA reverse transcription, cDΝA cycle kit L1310-01 obtained from Invitrogen Corp., 3985 B Sorrento Valley Blvd., San Diego, CA 92121, and a PCR amplification ώ ε e proved unsatisfactory because the primers developed were only good for amplifying small pieces of mRΝA. The inventors thereafter decided to develop their own technique for obtaining a 10 Kb mRΝA. The first part of this process was to optimize the reverse transcriptase reaction. The preferred reverse
transcriptase for making the first strand was discovered by trying variouε reverse transcriptaεe enzymes, including AMV (Avian Myelobastosis Virus) reverse transcriptase (M5101) and M-MLV (Moloney Murine Leukemia Virus) reverse transcriptase (M5301) which is modified to remove the ribonuclease H activity. See Tanese & Goff, Prec. Natl. Acad. Sci. U.S.A. 85:1977 (1988) . Both M5101 and M5301 were obtained from Promega Corp., 2800 Woodε Hollow Road, Madiεon, WI 53711. The M-MLV used according to Promega instructionε waε preferred as it gave the highest fidelity and the longest product length. It is therefore recommended to use the M-MLV and the following reverse transcriptaεe protocol: 2 μl 10X reverεe transcriptase buffer; 2 μl M-MLV reverse transcriptase (Promega) ; 2 μl dithiothreitol; 1 μl poly d(T)20; and 13 μl mRNA.
After the first strand was created, it was necessary to amplify the mRNA piece (after it was reisolated by phenol extraction and ethanol precipitation) . Since mRNA has a poly A end, a poly T primer was used. At the other end, a marker εequence waε needed and numerous posεibilitieε exiεted. While putting a marker caεεette on each end worked, that technique had a low probability of Iigating on to the low number first strand DNA. Since mRNA has a poly A end adjacent to where the carboxy end of the protein is coded, a method to label one end waε already available. Therefore, a method that would just label the one end was adopted and a terminal transferaεe was used. The preferred method is to use tne enzyme terminal transferase to add poly A at the 3' end of the first strand. This was done by allowing a single primer method to amplify both endε of the cDNA from the mRNA. The protocol is as follows: 10 μl terminal transferase buffer (Promega formula) ; 1 μl terminal transferase (Promega) ; 5 μl of
the first strand DNA from reverse transcription procedure described above; 1 μl oligo d(T)6.,2; 1 μl d(A); and 7 μl water; and incubate for 1 hr. at 37°c. Both the terminal transferase buffer and the terminal transferase were obtained from, Promega Corp. , 2800 Woods Hollow Rd. , Madison, WI 53711-5399, catalog no. M1871.
The DNA was then reisolated using phenol and ethanol precipitation, and PCR was used. The technique, which is described below, yielded DNA strands with a poly dA strand on one end and a poly dT on the opposite end. The problem of using PCR on such a long piece of DNA, which required long and accurate amplification protocol of the cDNA using poly T as the primer, was solved uεing the following Takara LA method of DNA amplification. The PCR amplification of cDNA was as follows: 1 μl DNA from the terminal transferase procedure described above; 10 μl 10X Takara LA buffer; 10 μl dNTPs (Takara); 1 μl poly d(T)20 primer; 1 μl Takara Ex Taq LA polymeraεe; 78 μl water; and 100 μl mineral oil. The PCR conditions were as follows: the initial dwell was 94°C. for 1 min.; the amplification cycleε (40) were: 94°C. for 30 sec; 55°C. for 2 min.; and 72°C. for 3 min.; followed by post dwell at 2°C.
The amplification initially showed a streak with multiple mRNA. To get the necessary specific primers, the cDNA from the initial amplification was amplified first with only primer (ii) of the 2 Kb coding for the non-repetitive region of the silk protein, which also incorporates the stop codon using 1 μl of the cDNA from the first PCR. This produces single strand cDNA only having a poly d(A) on one end. This new primer only amplifies cDNA coding for silk protein. This produceε a εelective library for silk proteins. This also gave a streak that amplified preferentially the cDNA from
the silk protein. Next, a PCR method was used whereby 1 μl of the above-described reaction waε used with the primer (ii) and poly d(T)20. When this was done, there were three distinct mRNA bands formed on an agarose gel with ethidium bromide. These mRNA bandε showed that three mRNA'ε of different sizes formed from the spider silk gene which would code for proteins of about 95 kDa, 190 kDa, and 220 kDa. The 190 kDA and 220 kDA proteins were fortified in natural spider silk, however, all three were formed. The same three proteins are produced both in the clones and the native spider dragline silk aε confirmed by electrophoreεiε. Thiε waε important to show cloning of the correct gene. These results convincingly indicate that three start siteε existed for this protein as they are homologous for the last 2 Kb according to PCR analysiε. The largeεt of these fragments is about 14 Kb long. The two largest fragments were subsequently cloned. The largest one was cloned by blunt end restriction opening of the pUClθ with Sma I and treated with CIAP as noted above in Example 2. The cDNA waε blunt end inserted by Iigating this into the vector as shown above in Example 2. This waε tranεformed with εupercompetent EX. coli XLl Blue MRF' with kit no. 200230 from Stratagene Cloning Systems, 11011 North Torrey Pines Rd., La Jolla, CA 92037.
Positive transformantε were assayed for insertion by checking the size of insertion with a 1% agarose gel. The positive inserts were then tested for the correct insert by using PCR and poly d(T)20 primer. The positives were also tested by the antibody methods discuεεed below. The positives passing the antibody tests for large mRNA were tested using SDS electrophoresis gels and found to give three different proteins also proving multiple start sites. One protein was slightly larger than the 2 Kb piece and the
other two proteins were slightly shorter than native εpider silk dragline protein. It was difficult, however, to get these high molecular weight proteins to stain with a Western stain, but this was also true with the native proteins.
Although there was no attempt to put in start codons or insure that the reading frame was correct, these clones produced a large amount of protein. In fact, some produced so much protein that growth was inhibited. To the inventors' knowledge, this was the first time that a culture showed this much synthesiε of the target proteins. As further explained in the fermentation section below, it was surprisingly discovered that culture conditions, such as lower temperatures, helped raise protein production. It was discovered that those proteins interfere with isolation of the plasmid DNA for sequencing, thereby making it difficult to get proper sequence while the DNA is coding for protein in the bacteria. However, the last part of the sequence of each of these proteins was the same (except for some minor differences at the amino end where up to 100 bp waε deleted from some clones) . These clones have the same sequence (the last 1900+ bases) at the carboxy end since they read the same DNA coding region.
Cloning from a Single Site Primer System
As stated earlier, primer (ii) is unique because it codes for the carboxy end of the major ampulate (dragline) silk protein. Nevertheless, it was necessary to develop a method that would get further into the amino direction and hopefully pull out the whole sequence. Two such approaches were developed. One was to use a shotgun method to make DNA clones, which is discussed below. It was believed unlikely that one would be able to clone the whole gene in one
insert and make protein by this method. Because the inventors knew that the carboxy end was unique for other spider silks of interest, they believed a method could be developed for PCR which only had to start with one known unique site. This technique, which is the second approach, involved Iigating caεsettes to the end of the DNA, although the use of a terminal transferase would have been as effective.
Example 4
To facilitate unique marking at the ends of the DNA whereby PCR primers could be developed that would bind to the site, a number of casεetteε from a Takara kit were developed. The cassette syεtems discloεed below were used.
Cassette 1. Sau3A I Cassette.
5 ' -GTACATATTGTCGTTAGAACGCGTAATACGACTCACTATAGGGA-3 ' 3' -CATGTATTACAGCAATCTTGCGCATTATGCTGAGTGATATCCCTCTAG-5 '
Cassette 2. EcoR I Cassette.
5' -GTACATATTGTCGTTAGAACGCGTAATACGACTCACTATAGGGAGAG-3 ' 3' -CATGTATTACAGCAATCTTGCGCATTATGCTGAGTGATATCCCTCTCTTAA-5'
Casεette 3. Hind III Cassette.
5' -GTACATATTGTCGTTAGAACGCGTAATACGACTCACTATAGGGAGA-3 '
3' -CATGTATTACAGCAATCTTGCGCATTATGCTGAGTGATATCCCTCTTCGA-5'
Cassette 4. Pst I Cassette.
5' -GTACATATTGTCGTTAGAACGCGTAATACGACTCACTATAGGGAGACTGCA-3 ' 3' -CATGTATTACAGCAATCTTGCGCATIΑTGCTGAGTGATATCCCTCTG-5 '
Casεette 5. Sal I Cassette. 5' -GTACATATTGTCGTTAGAACGCGTAATACGACTCACTATAGGGAGAG-3 '
3 ' -CATGTATTACAGCAATCTTGCGCATTATGCTGAGTGATATCCCTCTCAGCT-5'
Cassette 6. Xba I Cassette.
5 ' -GTACATATTGTCGTTAGAACGCGTAATACGACTCACTATAGGGAGAT-3 '
3 ' -CATGTATTACAGCAATCTTGCGCATTATGCTGAGTGATATCCCTCTAGATC*
Primer Cl.
5' -GTACATATTGTCGTTAGAACGCG-3 '
Primer C2 .
5' -TAATACGACTCACTATAGGGAGA-3'
Primer (ii) .
5' -GGCGAATTCACCCTAGGGCTTGATAAACTGATTGAC-3 '
See Isegawa et al. , Mol & Cell. Probeε 6:467 (1992!
To run thiε aεsay, it is necessary to digest the high molecular weight spider genomic DNA at one of the above restriction sites. The restriction digestion procedure is as follows: 2 μl 1 μg/μl genomic DNA; 20 units of an appropriate restriction enzyme (corresponding to one of the six above-mentioned restriction cassettes or others provided the same Restriction Cassette is used with the restriction enzyme) ; 5 μl 10X buffer for restriction enzyme; distilled water up to a total of 50 μl; and incubate at 37°C. for 3 hr.
This restriction digest is then cleaned and reconcentrated by ethanol precipitation and redissolved in sterile water. The cassette is then ligated to the respective DNA digest. The ligation reaction procedure iε as follows: 5 μl genomic DNA digest; 2.5 μl of an appropriate cassette such as cassettes 1-6 mentioned above) (20 ng/μl) ; 7.5 μl Takara ligation solution; and incubation for 3.0 min. at room temperature.
Thiε ligation reaction mix is then cleaned and reconcentrated by ethanol precipitation and redissolved in 5 μl of sterile water. Because the Taq in Takara's kit did not have proofreading activity or high fidelity, reagents and polymeraεe from the Takara LA PCR kit were uεed and resulted in very accurate transcription. The protocol used is described below.
The first PCR amplification mix had 2 μl of DNA solution; 1 μl of cassette 7 (primer Cl) ; 1 μl of cassette 9 (primer (ii) ) ; 10 μl of 10X LA Ex Taq polymerase buffer; 1 μl of Ex Taq LA polymerase; 10 μl of dNTPs (2.5 mM each); and water to a total of 100 μl.
The PCR conditionε were aε follows: initial dwell 94°C. for 1 min.; amplification (30 cycles): 94°C. for 30 sec; 55°C. for 2 min.; and 72°C. for 1-3 min.; and post dwell at 2°C.
After the first PCR amplification, a second PCR was conducted under the same conditions except that the genomic DNA solution waε replaced by 1 μl of the first PCR product and cassette 7 (primer Cl) was replaced with cassette 8 (primer C2) .
An agarose gel of the second PCR product showed bands for three of the cassette systemε: Pst I, Hind III and EcoR I. These were faint bands greater than 40 Kb in length and some greater than 100 Kb. While significant streaking of the gel occurred, it was assumed to be due to the extreme length of the PCR products aε the inventorε were unable to find any reportε of PCR of thiε length. Each of these PCR products was then cut out of the gel and repurified by Gene Clean. These products were blunt end fragments and directly cloned into pUC18 at the Sma I blunt end restriction sites and transformed into EX. coli XLl Blue MRF'. While all of these inserts deleted to some extent when inserted,
they nevertheless produced plasmid clones in exceεε of 20 Kb (typically about 23 Kb) which was long enough to insert the entire dragline spider silk gene. As discussed below, the EX. coli transformants did not grow very well in broth culture because of biochemical problems resulting from high production of silk.
These transformantε, like the cDNA tranεformantε previouεly diεcussed, did not grow very well and seemed to make cottony masεes resembling silk. Because of this, the present inventors set out to determine whether spider silk was being produced. The antibody and hemagglutination tests described below showed the production of large quantities of silk protein. SDS gel electrophoreεiε detected the presence of three proteins (which from the above-described cDNA work of Example 3 would be expected) and that the largeεt two fragmentε were full length matching native spider silk. Western blotting alεo showed the same resultε aε with the cDNA, i.e.. the smaller silk fragment stains very well. Owing to precipitation and other problems, the very large proteins did not Western blot positively like native silks. Example 3 worked like this example. However, in both cases and with native spider εilk the larger proteinε negatively stained.
There were also some notable problems with the growth of many of these clones -- similar to that observed with cDNA cloneε but strikingly higher in production. Some of these clones do not grow well in broth cultures like LB broth at 37°C. Interestingly, it was postulated by the inventors that a promoter came with the clones and aided the production rate. One approach to avoid sequencing problems of the full length silk associating with the plasmid DNA (which causes streaking on agarose gels) is to sub-clone into non- protein producing or low molecular weight protein
producing sub-clones. This problem iε more severe than that observed with the cDNA clones described above or the multimers described below. These clones like the cDNA clones produce large amounts of protein and can be used for large scale production. The last 2 Kb of the DNA sequence has been already determined to match the 2 Kb insert for which the sequence is completed.
Shotgun Cloning from Genomic Silk DNA
Although this particular method is known for cloning εilkworm DNA, the present inventors discovered that this technique iε also suitable for spider silk DNA isolation. However, it is expected that up to 50,000 clones will have to be screened by hybridization probes to find a suitable clone which might contain the whole gene. Unlike the other cloning methods discussed above, it is not expected that any of these clones (or only a small number of clones) will produce protein without extensive splicing. Therefore, the preεent inventorε set out to improve this technique. That improvement, which the present inventors developed, involves the use cf biotinylated probes, such as those used for cloning, attached to glass beads. It was found that this technique will enrich before cloning sequences having at least a portion of the silk gene. The biotinylated probes select for DNA sequences having the specific region hybridizing to the probe. Therefore, DNA fragment may not have the whole gene. Nevertheless, this technique is used to obtain the spider silk gene and as a starting point for making protein expression clones. Compared to the cloning techniques described in Examples 1-4, these shotgun methodε are rudimentary but still suitable methods for cloning Nephila and other spider silk proteins.
Example 5
Using hybridization probes for selecting clones with biotinylated probes is known. For example, a Sigma kit (Cool-1) , Sigma Chemical Co., P.O. Box 14508, St.
Louis, MO 63178-9916, provides the reagents for final development of dot blotε of cloneε on εigma nitrocelluloεe membrane blotted according to BioRad procedureε. There are many of theεe procedureε and moεt people skilled in molecular biology have practiced this basic technique.
The technique for concentrating DNA segmentε hybridizing to biotinylated probes iε not known aε well. In this system, DNAL (Lake Success, NY) M-280 glasε beadε were uεed for pre-enrichment of genomic DNA using the following procedure. First, the biotinylated probes and Dynabeadε M-280 Streptavidin were mixed in a microcentrifuge tube. 100 μl of the beadε and 100 μl of biotinylated probe (1 μg/μl) were mixed together and allowed to bind for 10 min. at room temperature.* The bead iε held in a centrifuge tube with a tube magnet and the liquid is gently poured off. The beads are then washed 3 times with TE buffer containing 0.1 M NaCl. 100 μl of genomic DNA that has been pre- denatured at 95°C. for 2 min. is added to the beads. The beads and the DNA are allowed to hybridize far 2 hr. at 42°C. using an equal amount of binding solution that is 2X and consists of 10 mM tris, HCl (pH 7.5), 1 mM EDTA and 2 M NaCl. The temperature is then lowered to room temperature and the beads are washed 3 times in the nybridization solution. The enriched DNA is then eluted by using 0.15 M NaOH containing O.l M NaCL. The DNA is concentrated to 5 μl in water and cloned by insertion into the pUC18 vector at the Sma I site. The correct pieces are still selected using various biotinylated probes that bind to spider silk DNA
sequenceε. Positive clones are sequenced. This technique is very effective but takes quite a bit a work for selection. Enrichment of the DNA can be obtained εo that only 500 cloneε or leεε need to be εcreened. Without this enrichment, however, 200,000 to 20 million clones must be screened to obtain a clone having the silk gene.
The Multimerization Process
Using the two primer PCR cloning techniques described in Examples 1 and 2 and more than 20 different primerε baεed upon Nephila type sequences, the 2 Kb inserts were the longest spider silk pieces cloned. Because of this, it was theorized that a different technique would be required to make larger fragments. It was considered necessary that the technique obtain additional sequence information from parts of the protein coding towards the amino end because, with the available information from the protein sequencing, larger fragments were not produced. Although the 2 Kb piece was over 40% of full length, multimerization was considered necessary to increase strength characteristics -- as strength generally varies with the size of the εilk polymer. Therefore, the inventors wanted to multimerize the 2 Kb insert to make a larger protein than the natural gene.
The present inventors of the present invention postulated that PCR would make a suitable method to multimerize these insertε aε it avoids the repetition cf reported sequences. The multimerization processes of the present invention are shown in the following examples.
Construction of PCR fragments with various uεeful restriction sites was accomplished by modifying the overhangs of the current beginning and ending primers. Other beginning and ending primers like primers (i) and (ii) described above have different restriction siteε, in addition to having the stop frame codons deleted so that the protein would continue to be translated into mRNA through the sites, enabling longer constructs to be made. The start codons were left in initially so there would be multiple proteins to help check for deletions and to increase the translation. The primers used to make the differing 2 Kb inserts with unique restriction sites are shown below. These are referred to as primers (xxi) - (xxvi) .
Primer (xxi) with a BamH I site.
5' -GGCGGATCCGGATCCATGGCAGCAGCAGCAGCAGCAGCT-3 '
Primer (xxii) with a Hind III site. 5 ' -GGCAAGCTTGGATCCATGGCAGCAGCAGCAGCAGCAGC -3 '
Primer (xxiii) with a Sal I site.
5' -GGCGTCGACGGATCCATGGCAGCAGCAGCAGCAGCAGCT-3 '
Primer (xxiv) with BamH I εite and no stop codon. 5' -GGCGGSTCCACCCAAGGGCTTGATAAACTGATTGAC-3'
Primer (xxv) with Hind III site and no stop codon. 5' -GGCAAGCTTACCCAAGGGCTTGATAAACTGATTGAC-3'
Primer (xxvi) with Sal I site and no stop codon. 5' -GGCGTCGACACCCAAGGGCTTGATAAACTGATTGAC-3 '
Example 6 (a 4 Kb multimer construct)
The 4 Kb construct of this Example waε made by PCR of primerε (i) and (xxv) with a 2 Kb insert in pUC18. Primerε (ii) and (xxii) were used in a separate reaction conducted in accordance with Example 2 above except that a 2 Kb starting plasmid was used instead of genomic DNA. Using the LA (long and accurate) PCR technique, the DNA fragments discovered were the 2 Kb pieces with new restriction siteε and two bands reprεεenting the entire plaεmid.
Theεe bandε were subεequently εeparated by a 1% agaroεe gel (electrophoresis at 70 V for 90 min. on a 8 cm gel) -- Gene Capsules (Geno Technology, Inc. St. Louis, MO 63108) according to company instructionε. The bandε were cut with both EcoR I and Hind III reεtriction enzy eε and the vector 2 μg waε cut with EcoR I and treated with CIAP as described above in Example 2. Then, one half of each of the two 2 Kb pieces and the vector were repurified by phenol extraction and ethanol precipitations and then dissolved into 10 μl of TE buffer. TE buffer is described in Sambrook et al. A 5 μl aliquot of each was added to a ligase reaction (aε deεcribed above in the ligation protocol in Example 2) and ligated together. Theεe were electroporated into E. coli XLl Blue MRF' cells (Kit No. 200230), EX. coli TOPP cells (Kit No. 200241) and EX. coli Sure cells (Kit No. 200238) using the normal bacterial protocol supplied with the Invitrogen electroporator, Cat. No.
S1670-01 obtained from Invitrogen Corp., 3985 B Sorrento Valley Blvd., San Diego, CA 92121. The EX. coli cells were obtained from Stratagene Cloning Systemε, 11011 North Torrey Pineε Road, La Jolla, CA 92037. Sure cellε gave better results as fewer transformantε had deletions. The succesεful tranεformantε made proteinε of 94 and 188 kDa, the
latter of which is εimilar to the 190 kDa protein reported in the literature for native εpider εilk.
Example 7 (a 6 Kb multimer construct)
The 6 Kb conεtruct of thiε Example waε made by PCR of 3 fragmentε uεing the procedure deεcribed above in Example 2. Thiε procedure conεisted of using three 2 Kb constructs and the following primer sets: set 1: primers (i) and (xxiv); set 2: primers (xxi) and (xxv) ; and set 3: primers (xxii) and (ii) .
These were constructed into pUC18 in the same manner as described in the 4 Kb multimer construct of Example 6. While it was discovered that, in εome caεeε with Sure cellε, deletion did not occur creating a protein larger than native silk, some deletion did occur in many cases as judged by agarose gels of the PCR product using primers (i) and (ii) and transformant vector DNA. The Sure cells were preferred because they were recombinant deficient. As expected, as the DNA got above a certain size, it became less stable and deleted out repeats.
Example 8 (a 8 Kb multimer construct)
The 8 Kb construct of this Example was made exactly as the 6 Kb construct of the above Example with the exception that 4 separate 2 Kb pieces were made from the following four setε of primerε: set l: primers (i) and (xxiv); set 2: primers (xxi) and (xxv); set 3: primers (xxii) and (xxvi); and set 4: primers (xxiii) and (ii) .
These were inserted the same way as the other inserts of Examples 6 and 7. Even though deletions occurred in almost all cases, proteins larger than natural silk were produced indicating that this multimerization
technique could be uεed to make synthetic silks with superior properties. Using this technique and full length DNA, the sequence could be changed to produce multimer units of natural silk DNA, the final product having much higher molecular weight than normal. Some of these cloneε produced protein similar in size to or larger than full length natural silk.
Clones from other techniques such as the cDNA and single site systems described above could also be pieced together to make other multimers. Clones up to 800 kDa are posεible with the multimerization techniques of this invention using full length clones or pieceε therefrom.
Vectors and Production Systems
With the cloning of spider silk proteins, EX. coli and pUC18 are the preferred initial production systems. Both have good stable expression of high fidelity and excrete the silk protein through their cell membrane. Although only one example of an expression system is given, the specific insertε coding for natural proteinε or multimerε derived from them are applicable for use in any vector or genomic incorporation system. Because the potential list of vectorε and hosts is prohibitively long, only a few examples are given below.
Bacterial systems
EX. coli expression systems are preferred because they have the necessary biochemical machinery to produce very high levels of recombinant proteins and excrete them outside the cell membrane. They are also easy to grow using εimple fermentations. Additionally, many of the major problems for protein production with this
system have been overcome as theεe are among the moεt common of expreεsion systems. pUC18 is among the most commonly used vectors. Other vectors based upon lytic phage, phagamids, and shuttle vectors are also possible as expression insertion systems in addition to the common man-made plasmidε of which pUC iε just one. Exampleε of such plasmidε include pBR322, pSP-64, pUR278 and pORFl. Exampleε of phage vectorε include lambda, 12001, lambda gtlO, Charon 4a, Charon 40, M13mpl9 and other phage modified from natural bacterial phage.
Bacilluε expreεsion systemε including Ex. subtilis syεterns can also be used. These bacteria have the advantage of good secretion by the host, which results in less processing steps and processing costs. Although an expression cassette might be used, it has been found unnecesεary with the vector host systemε studied thus far. One phagemid that can act as an EX. coli and Bacillus shuttle vector is pTZ18R which can be obtained from Pharmacia (Piscataway, NJ) .
Many other bacterial systemε can be used for expresεion.
Depoεited Clone
A representative clone has been deposited with the American Type Culture Collection (12301 Parklawn Dr. Rockville, Maryland 20852) on June 2, 1995 and given ATCC No. 69832. The deposit consists of EX. coli XLl MRF' ceils, stiain designation PA21, containing a pUClθ plasmid (23 Kb) with a full length spider silk gene capable of expressing full length Nephila clavipes silk protein.
Yeastε and mold εvεtemε
Saccharomyceε cereviεiae. Schizoεaccharomcyceε pombe. Pichia pastoris, Asperillus s . , Hansenula s . , and Streptomyces sp. can be used as expresεion systems. However, with the exception of Aspergillus and Pichia systems, there is little evidence that these systemε will produce more protein than bacteria or be amenable to scale-up. These systems, however, might be more desirable to produce USP or food grade materials since bacterial fermentationε have toxinε and pyrogenε associated with them, whereas many of theεe yeaεt and mold εyεtemε have already been shown to be safe as food grade materials.
Plant transformation systems
Plant systems can be used for production of transgenic proteins such as silk. Although the quantity of protein may be lesε than that produced in a microbial system, plant cultivation is rather inexpensive. Agrobacter type transfection systemε that allow genetic incorporation into the plant genome can be used. These may be inserted by bacteria such as Agrobacter tumafaciens LB4404 using gene gun insertion, electroporation or a number of other insertion tools. Once inserted, they can be incorporated into the plant genome in a stable and inheritable manner. These plant systems have a number of benefits, such as being conventionally grown and harvested in large tonnages. Farmers have experience raising such industrially important plants as tooacco, soyoean, rape seed and other widely grown crops, which are the main plantε of interest for silk production. Procedureε presently exist for purification of high molecular weight proteins from tobacco and soybeans.
Insect systemε
Baculovirus expression systems can be used and are well known for high-level expression of recombinant proteinε in insect cell lines. Replication and efficient transfection is accomplished by a number of vectors including pBacPAK6, pBacPAKδ or pBacPAC9. These can be used for high level expresεion although they may not be aε coεt effective aε other systems.
Other animal systemε
There are alεo many vectors that can be used for insertion into a variety of animals. Although, they are not now vector host systemε of commercial value, there might be applicationε whereby the protein would be helpful in the future.
Fermentation Procedures
The firεt fermentationε of tranεfected hoεtε were done in LB broth which consists of 10 grams of bactopeptone, 5 grams of Bacto yeast extract and 5 grams of salt and distilled water to a final concentration of one liter. In this particular broth, either a large amount of precipitate or a cottony mass of spider silk-producing bacteria was observed. This observation was important because it indicated that the proteins were being excreted across the cell membrane. However, these high excretion rates appeared to make the cells somewhat leaky. Therefore, increasing the physiological salt concentration is likely to stabilize the culture.
It was discovered by the inventors that protein production increased at lower temperatures, in particular at room temperature and below, it was also discovered that, at higher temperatures, the protein
disappeared more rapidly (within 5 days) in the fermentation media than at room temperature or below. This phenomenon indicated that a protease was being induced at the higher temperatures around 37°C. This protease activity is noteworthy as many proteases, such as lysozyme and proteinase K, do not seem to degrade spider silk protein. These undesirable metabolic effects are minimized at lower temperatures. This may be due to the induction of shock proteins at lower temperatures.
The composition of the fermentation media was also found to affect the protease activity. For instance, urea-SDS gels of a two day culture did not show protein degradation when grown in LB broth, but when a culture was grown on LB media supplemented with glucose (10 grams of glucose, 10 grams of peptone and 5 grams of yeast extract and distilled water to one liter) , there was masεive protein degradation after 24 hourε. The only difference between the εupplemented LB media and the LB broth waε that LB broth contained 10 gm/1 of NaCl, whereaε the εupplemented media contained an equivalent amount of glucose.
As a result of the discovery of this protease problem, protease inhibitors were inveεtigated. It was believed that if an inexpensive protease inhibitor could be found and inserted into the culture media, it would be advantageous for fermentation scale-up. The compoundε tested included ZnCl2, copper sulfate, disodium EDTA, sodium chloride, boric acid, ethylene glycol bis (B- axα notithyi ether) , pnenylmethyl sulfonyl fluoride, N,N,N' ,N' -tetracetic acid, 1,10 phenanthroline, 1,10 phenanthroline iron complex, sucrose, glucose, lactose, fructose, glycerol, peptone and yeast extract.
The most effective inhibitors found were salt additions from NaCl or KCl. Boric acid was also found to be a good inhibitor. None of the other compounds were effective. In fact, the simple sugars, and lactose and glucose in particular, promoted protease activity. Peptone and yeast extract did not affect protease activity. Theεe compoundε were teεted with AOAC Official Method 969.11, a method for testing proteolytic chillproofing enzymes in beer. To perform this test, 1 ml of the culture was taken and tested. When an active protease was present, the solution cleared in just a few εecondε. Protease negative samples showed cloudiness after a ^ hr. at 60°C or overnight at 20°C. This test was used as a quick quality control tool to εcreen various culture media for its proteolytic enzyme-inducing ability.
Fermentation was attempted using various media. It was found that complex media worked very well. However, acceptable protein production was obtained using 10 times less peptone and yeast extract than contained in LB broth. Thiε simpler and less expensive media produced considerable protein. This media consisted of the following ingredients: 1.2 g dipotassium phosphate, 1.1 g monosodium phosphate, 4.0 g sodium chloride, 0.45 g magnesium sulfate, 2.0 g ammonium sulfate, 0.04 g sodium nitrate, 0.03 g calcium chloride, 0.02 g ferric sulfate, 0.01 g manganese sulfate, 0.01 g boric acid, 0.0005 g sodium molybdate, 0.005 g cobalt chloride, 0.5 g glycine, 1.0 g alanine, 1.0 g yeast extract, 10 g glycerol, distilled water to 1 liter, pn adjusted to 7.0. A wide range of culture media compositions can be used for the fermentations of this invention. These media can range in composition from salts, glycerol (or other carbon sources) and yeast extract or some other source of minor nutrients.
While simpler media is less expensive, it generally resultε in lower levelε of silk protein.
The other main fermentation conditions that must be optimized are oxygen, nutrient level and temperature. Anaerobic conditions at 30°C. has been found to be preferred. In addition, the carbon source should be added at a relatively high level to maximize growth and protein expresεion. For example, 10 gramε of glucoεe and 10 gramε of glycerol per liter haε been used.
Antibody Testing
The antibody testing that waε developed to determine whether the εpider silk protein was expresεing in the E. coli host was done with three animal hoεtε using silkworm εilk and εpider major ampulate gland silk.
To develop these antibodies, the silkworm protein was taken from fifth star Bombyx mori caterpillars before they spun a cocoon. By selecting such caterpillars, the silk was viscous and gave the caterpillar a translucent appearance that was recognizable. The viscouε liquid εilk was removed by disεection using aseptic techniques. This εilk could then be added to the adjuvant directly. Alternatively, spider silk from the major ampulate gland of the spider could be drawn. However, it was necessary to dissolve the spider silk. Thiε was done by suεpending it in 8 M LiBr with heating to 95°C. for 5 min. This spider silk and the silkworm silk were uεed for making antibody to the silk.
To make the antibody, the LiBr was replaced with 8 M urea and finally in 2M urea by centrifugation. Once the εample iε in urea, either sample of silk is mixed (1:10) with 10 ml of Freund's complete adjuvant. Thiε iε injected IP into the mice, rabbits or goats to
„ ,„„,, ,. PCT/US96/13767 97/08315
- 44 -
develop antibodies. On day 21 through 28, the animal was boosted with the silk and Freund's incomplete adjuvant. By the fifth week, it is possible to collect blood weekly and collect the antibody in the serum. The serum was used for running hemagglutination testε or Western blots. Using this procedure for mice, rabbits and goats, blood was taken and the serum separated. This gave polyclonal antibodies to both silkworm and spider silk from each type of animal. These sera were tittered for antibodies and all found to be at leaεt a titer of 256 by εtandard hemagglutination tests.
Hemagglutination Test
The hemagglutination tests were performed by coating 1% RBCs (Sigma Cat # R-3378) . The dissolved silk was added (lmg) to 1 ml of 1% RBCs. This was vortex mixed a few times at room temperature and refrigerated overnight. The next morning, the RBCs are washed by centrifugation in phosphate buffered saline (pH 7.2) three times to remove any non-adhering protein. The sensitized RBCs were then εtable in the refrigerator for 2 weekε or longer.
To run a hemagglutination test on the sera, 25 μl of antisera was serially diluted (2 fold dilutions) and 25 μl of sensitized RBCs were added. Control wells were also serially diluted similarly and non-sensitized (25 μl) were added. The microtiter plate was rocked at room temperature for 10 min. and the plates were incubated at room temperature for 90 min. without being disturbed. They were evaluated by the method of Rose and Friedman, (Manual Of Clinical Immunology, 2nd ed. , Amer. Soc. Microbiol. (1980)). Many silks have a similar folding structure due to the similarity of their repeating units. Therefore, it was thought that
there might be some cross reactivity due to the tertiary structure being similar. It waε found that εilkworm antisera cross reacted with spider silk protein senεitized RBCs and that spider silk antisera cross reacted with silkworm protein RBCs. Thiε cross reactivity became a major tool as a culture could be tested against both sets of antibodies with confidence that the silk was not due to another protein that E. coli made.
We also found an additional .screening technique that was based upon the coating of RBCs with silk ar.iigens. It waε found if we sonicated washed cells, separated the cell membranes and took the supernatant, we could use this instead of the sera by two-fold serial dilutions. Upon putting 25 μl of silk sensitized cells on RBS's they give a claεsical hemagglutination test that could be used as a first screen of the transformants. It is theorized that the silk protein has sticky ends that will attach to other silk protein in solution and crosslink the RBCs. This would use the same mechanism whereby the silk protein associates and falls out of εolution. We could not find any other reference to a protein assay based upon this mechanism. Therefore, we expect that it is a very specific assay for silk and silk-like proteins.
To run the hemagglutination test on the colonies, bacteria cultures (1 ml) were washed 3 times by centrifugation in PBS and brought up into 100 μl of
PBS. They were sonicated using a Branson 450 sonicator with a 1/8 inch tip at 40% power and 20% duty cycle for two minutes in an ice bath. This solution is used for senεitizing the RBCs. The assay was run the same way as above except each was for a different bacterial isolate. In all caseε, cultures that were successfully producing a silk protein had a titer of at least 16 and
usually 256. Thiε procedure waε used to screen the 10 most promising isolateε as found by the above agarose gel of the plasmid and blots. In the case of the 2 Kb insert only the best few isolates were saved for further work.
Purification of Silk Proteins
The present invention also encompasses the techniques for purification and spinning the silk. These steps are essential for the processing of the protein into its final form. The protein can be used as a coating, extruded into a fiber, or made into a polymeric film.
The purification of silk protein from the fermentation media can be accomplished by a two step process. First, the bacterial cells and precipitated protein can be removed by continuous centrifugation. The remaining material present in the fermentation broth can be separated by ultrafiltration since most of the protein above a molecular weight of 80,000 is silk. The protein silk streams from the continuous centrifugation and ultrafiltration procedures can then be combined. The bulk of the remaining proteins can be found in the bacterial membranes. By rupturing the bacterial cells using ultrasound, the cells are opened and the εilk protein in them iε removed.
An important discovery of the present invention is the use of ultraεound to εolubilize the spider silk, provided it was not washed and completely dried. This re-solubilized silk protein solution can then be centrifuged to remove the cell membranes. After the cell membraneε are removed, the protein can either be further purified by ultrafiltration or spun. In order to spin the silk, it is important to maintain the silk in solution. Prior processes, however, used very harsh
chemicals to maintain silk solubility for spinning operations.
Various compounds will keep the silk protein from re- precipitating prior to the spinning process. These include a variety of salts, lithium salts, sodium and potaεεium hydroxide, urea phoεphate, guanidine hydrochloride, urea, and hexafluoroiεopropanol -- all of which dissolve the silk. It was also found by the present inventors that after purification by ultrafiltration, further purification can be effected by alcohol precitation by adding ethanol, methanol, other alcohols or similar solventε. This purified silk protein material could be redissolved by ultrasound or by adding one or more of the above salt compoundε. The preferred compounds as determined by cost and environmental considerationε for εilk protein solubilization are sodium and potasεium hydroxide, εodium chloride, potassium chloride and lithium chloride or lithium bromide used in combination with ultrasound or with alcohols for protein purification.
Like other silk proteins, spider εilk protein is not easily solubilized. Although there is data that εuggests that εpider silk may be soluble in harsh chemicals like formic acid (88%) , the present inventors found that it caused degradation of full length protein. However, the present inventorε found that εilk fiberε could be reεolubilized in LiSCN, LiBr, LiCl, urea, hexafluoroisopropanol, guanidine hydrochloride and similar denaturants. Once the silk proteins are solubilized, less potent denaturants including urea can be used to prevent the protein from re-precipitating. It most likely will be preferred to use soluble protein before irreversibly spinning into a thread. Therefore, silk protein that has been
resolubilized from completely dry silk protein and silk protein that has never been dried completely after being recovered from the fermentation process are recommended for the spinning operations.
Further Proceεεing of Silk Protein into Fabric
General Processing of Silk
Silk protein from silkwormε are typically proceεsed in the following manner. To make the silk fibers strong enough for weaving, up to five fiberε are twiεted together. After the first reeling, the silk iε rewound onto εkeins, which are twisted together.
The raw silk then goes through several processeε called throwing. The skeins are washed and dried and wound on large spoolε or bobbinε. Theεe bobbinε are placed on doubling frames where single strands are doubled and twisted together to obtain the desired thread size.
This thread is then twisted and drawn out by the spindleε of a throwing frame.
Bobbins of silk from the throwing frame are then placed in water and the silk is stretched between rollers.
The degree of elongation on the throwing frame affects the fiber diameter. On the stretching frame, the thread is made smooth and even. Before the cloth is finally woven, the thread of thrown silk iε boiled to remove any residual water soluble proteins or other gummy substances. Because the boiling step lessens the weight of che =>ilλ, the silk is dipped in salts of iron or tin in order to regain some of the lost weight. During this dipping step, the silk fiber takes up some of these saltε and becomes heavier but does not lose its luster.
Specific Processing of Spider Silk Protein
The spider silk proteins produced by the above- deεcribed methodε can be proceεεed into fabricε in the same manner as silkworm proteins. This requires spinning or extruding the protein or protein solutions to obtain silk filaments which may range in diameter from 5 μm to 200 μm or higher. The first step in the proceεε is to concentrate the silk proteins from the fermentation solution. This concentration step can be accomplished by a number of methods including the use of membrane technologies which permit only materials of a given molecular weight range to pass. One disadvantage of using these membranes is cost. Other more coεt effective methods to concentrate the silk proteins and remove the host vector include continuous or batch centrifugation. In addition, ultrasound energy can then be used to lyse the bacterial cell wall and allow the silk proteins produced within the cell wall to escape into the aqueous media. To separate the silk proteins from the bacteria cell walls, higher concentrations of saltε are favored.
At this point, the protein solution can be precipitated from media by various alcohols. Useful alcohols include methanol, isopropanol and ethanol. The prior art teaches that at this point in the process the silk proteins can be dissolved in lithium salts and organic solvents containing fluorine. However, that procedure is expensive and a severe environmental challenge. In a more preferred embodiment of the present invention, the spider silk proteins are concentrated using alcohols or membrane filters and then maintained in solution in a viscous form by using aqueous solutions of sodium chloride in combination with ultrasound, until they are extruded. If necessary, urea, sodium and potasεium hydroxide or lithium salts can be added
as diεclosed by prior art processeε. However, becauεe of the sodium chloride and ultrasound, only very low concentrations of these materials may need be used. It should be noted that excessively high ultrasound energies, prolonged ultraεound use during purification or high molarity concentrations of lithium salts can reduce the molecular weight of the silk proteins.
Once the protein is extruded using small diameter tubing or other methods that produce small diameter filaments, the protein can be processed in a manner similar to silkworm silk. Once the protein iε exposed to air and dried, it is no longer soluble in sodium chloride or by ultrasound.
Similar equipment to that used for silkworm can then be employed to preεtretch or throw the silk protein. Boiling, εimilar to that used for silkworm, can also be used. The majority of the weight loss from boiling is not water soluble protein as with silkworm fibers, but rather the residual salts and water soluble nutrients from the fermentation media. While a 20-25% weight loss is common from raw silkworm silk during thiε process step, weight losε of leεs than 5% is expected from the spider silks of the present invention when exposed to the boiling water to clean the final silk or to prepare it for dying.
By using the processes of the present invention, the natural colors of the silk protein can be obtained by selecting primers which encode further into the genomic DNA. White, yellow, pink and light purple colors have been obεerved with the εpider εilk proteins produced from the clones and processes of the present invention. The selection for natural color is of value for the manufacture of woven textile fabrics since in many
cases it will eliminate the need and associated cost of color dying.
The spider silk protein filamentε can be treated in a manner εimilar to silkworm silkε by winding or twiεting two or more threadε together to make larger yarnε. In addition, theεe yarnε can be interwoven with carbon or graphite fibers, boron or boron coated graphite fibers, or Kevlar* to make woven materials of unusually high strength for body armor and other applications.
Conversely, by using smaller yarns, consisting of three to five filaments and only pure spider silk, fabrics with a very smooth feel and luster can be manufactured. The elasticity and other properties of the final weave can in part be controlled by the processing of the filaments or fibers after the extrusion or spinning process. A major variation in procesε parameterε from silkworm processing is the degree of prior elongation or stretch on the individual filaments as they are being drawn or extruded from the initial protein solution or afterwards in a throwing process standard to the silkworm industry.
In addition to the above, the high strength properties of the spider silk protein filaments permit other processing variables. One such process variable is the on line coating of the silk threads uεing variouε materials to impart color, increased strength, luster, iridescence and other qualities which increase the marketability of the fabric on the basis of appearance, feel or strength. The on line coating can be accomplished by several methods including running the spider silk filaments through various baths or troughs during the extrusion, rewinding or throwing steps. On line vapor deposition can also be used.
On line vapor depoεition of aterialε onto silk proteins must take into consideration that some residual salts or other fermentation compounds may be present when the filament is initially formed. In addition, these filaments tend to remain wet after being formed unless dried by ovens, fanε or other meanε. In some caseε, boiling after extruεion may be preferred to remove all traceε of the fermentation media and resolubilization chemicals -- both of which may invoke an allergenic responεe from the skin when woven into fabrics. Materialε that can be vapor depoεited onto spider εilk proteins include the oxides of tin and titanium. These oxides form a layer on the filaments, the thickness of which depends on the oven conditionε. Although titanium coatingε may produce higher strength fibers, some people have allergic reactions to titanium dioxide coatings and this may limit itε uεe to applications other than clothing. Tin oxides, however, are GRAS (Generally Recommended As Safe) for human skin contact and therefore can be used in clothing applications.
Films of spider silk protein can be manufactured by several methods including casting wherein the silk protein solution is poured and spread onto sheets or by using rollers. Films may also be modified by the addition of compounds to the protein prior to casting or rolling. This would include the incorporation of active molecules which may act as fragrances, flavors, absorbents or reactants to various biological reagents and weaponε. Filmε may also have colors added during pio;eusing or a natural color from a silk clone protein can be selected to impart a natural color.
Claims
1. A procesε of producing a DNA fragment encoding εilk protein, compriεing the steps of: selecting target DNA harvested from a silk-producing spider, said target DNA comprising a plurality of repetitive and non-repetitive regions; selecting a single strand DNA primer of at least 10 nucleotides having a DNA sequence that is complementary to a region in said target DNA; and repetitively combining the DNA primer with melted target DNA and incubating said combined DNA primer and target DNA with nucleotides and a DNA polymerase having proofreading ability to produce said DNA fragment, wherein said DNA fragment is complementary to said target DNA and is at least 2 Kb.
2. The procesε according to Claim 1, comprising the step of using two different DNA primerε.
3. The process according to Claims 1 or 2 wherein said target DNA is cDNA made by reverεe transcription of full length mRNA coding for spider silk; adding a primer site to the amino end of the first strand cDNA made thereof; and using the poly dT region of the cDNA aε a firεt polymeraεe priming region.
4. The process according to Claims l or 2 wherein a second primer site is created at the unknown end of the DNA uεing a ligation caεsette.
5. The process according to Claims 1 or 2 wherein a second piiiuer siL is created at the unknown end of the DNA using a terminal transferase to make a primer site selected from the group consiεting of poly dT, poly dA, poly dG and poly dC.
6. The process according to Claims 1 or 2, comprising the step of selecting a spider of the genus Micrathena. Mastophora. Metepeira, Araneus. Argiope. 1-Iephiia or Gasteracantha.
7. The procesε according to Claim 6, comprising the step of selecting a primer DNA represented by sequences (i) - (xx) :
GGCGAATTCGGATCCATGGCAGCAGCAGCAGCAGCAGCT;
GGCGAATTCACCCTAGGGCTTGATAAACTGATTGAC;
GCATGCACGCATGGTGCATGGATGC;
TTCGAATTCATGGGCCCTGGACAACAAGGACCATCTGGACCT;
GGAAGGCGGGCAGTGAGCGCAACGCAATTAATG;
GAYGAYGGNAAYGCNGT;
TGNTGNCCSGTTCG;
CGSCGKCGSCCACGSCCSCG;
GTTAAATGTAAAATCAAGAGTTGCTAA;
GGCCAATCTCTTTTGAGTGCATTTTAA;
TAAGCAACTCTTGATTTTACATTTAAC;
TTAAAATGCACTCAAAAGAGATTGGCC;
TCAGCAGAATCTGGACAACAAGGCCCA;
CCNCGNCCNCTYCC;
GGTGCAGCAGCAGCAGCTGCWGG;
GGTGGTGCCGGACAAGGAGGMTATGGAGGWCTTGGA;
GGWGGACGAGGTGGATTA;
GATAAAAAGAAATATGCTGCAGAACTTCACTTGGTTCAC;
CARGCNGGNGCNGCNGSNGGNGGNTTYGGNCC; and
GGNGGNGGNGCNGGNCARGCNGGNGCNGCNGSNGGNGGNTTYG GNCCNGGNGCNGGNGGN,
wherein N = G, A, T, C; V = G, A, C; B = G, T, C;
H = A, T, C; D = G, A, T; K = G, T; S = G, C; W = A, T;
M *= A, C; Y = C, T; and R = A, G.
8. The procesε according to Claim 7, wherein said target DNA is selected by hybridization tc a DNA probe
having the sequences (i) - (xx) which iε reverεibly bound to a support to enrich for the silk-encoding DNA fragments.
9. The process according to Claim 6, wherein said DNA fragment is at least 5 Kb.
10. A DNA sequence encoding spider silk protein, said DNA sequence compriεing a plurality of repetitive and non-repetitive regions and having a length of at least 2 Kb.
11. The DNA according to Claim 10, wherein said DNA sequence has a length of at least 5 Kb.
12. The DNA according to Claims 10 or 11, wherein said εpider iε of the genuε Micrathena. Mastophora. Metepeira. Araneus, Argiope, Nephila or Gaεteracantha.
13. The DNA according to Claim 11, wherein said spider is Nephila clavipes.
1 . The DNA according to Claim 12, wherein said DNA comprises the sequence illustrated in Figure 1.
15. A multimerization process, comprising the steps of: selecting a target DNA encoding silk protein harvested from a silk-producing spider, said target DNA comprising a plurality of repetitive and non-repetitive regions; selecting a first pair of different DNA primers, said first pair of DNA primers both being complementary to a region in said target DNA, at least one of said first pair of DNA primers being represented by the sequenceε (i) - (xxvi) :
(i GGCGAATTCGGATCCATGGCAGCAGCAGCAGCAGCAGCT;
(ii GGCGAATTCACCCTAGGGCTTGATAAACTGATTGAC;
(iii GCATGCACGCATGGTGCATGGATGC;
(iv TTCGAATTCATGGGCCCTGGACAACAAGGACCATCTGGACCT;
(v GGAAGGCGGGCAGTGAGCGCAACGCAATTAATG;
(vi GAYGAYGGNAAYGCNGT;
(vii TGNTGNCCSGTTCG;
(viii CGSCGKCGSCCACGSCCSCG;
(ix GTTAAATGTAAAATCAAGAGTTGCTAA;
(x GGCCAATCTCTTTTGAGTGCATTTTAA;
(xi TAAGCAACTCTTGATTTTACATTTAAC;
(xii TTAAAATGCACTCAAAAGAGATTGGCC;
(xiii TCAGCAGAATCTGGACAACAAGGCCCA;
(xiv. CCNCGNCCNCTYCC;
(xv GGTGCAGCAGCAGCAGCTGCWGG;
(xvi GGTGGTGCCGGACAAGGAGGMTATGGAGGWCTTGGA;
(xvii GGWGGACGAGGTGGATTA;
(xviii GATAAAAAGAAATATGCTGCAGAACTTCACTTGGTTCAC;
(xix CARGCNGGNGCNGCNGSNGGNGGNTTYGGNCC; and
(xx GGNGGNGGNGCNGGNCARGCNGGNGCNGCNGSNGGNGGNTTYG GNCCNGGNGCNGGNGGN;
(xxi GGCGGATCCGGATCCATGGCAGCAGCAGCAGCAGCAGCT;
(xxii GGCAAGCTTGGATCCATGGCAGCAGCAGCAGCAGCAGCT;
(xxiii GGCGTCGACGGATCCATGGCAGCAGCAGCAGCAGCAGCT;
(xxiv GGCGGSTCCACCCAAGGGCTTGATAAACTGATTGAC;
( xv GGCAAGCTTACCCAAGGGCTTGATAAACTGATTGAC; and (xxvi GGCGTCGACACCCAAGGGCTTGATAAACTGATTGAC
producing a first DNA fragment by repetitively combining said first pair of DNA primers with melted target DNA and incubating said combined DNA primers and target DNA with nucleotides and a DNA polymerase having proofreading ability to produce said first DNA fragment, said first DNA fragment being complementary to said target DNA and at least 2 Kb; said multimerization process further comprising selecting a
second pair of different DNA primers, at least one of said εecond pair of DNA primers being different than both of the sequences of said first pair of DNA primers, and at least one of said second pair of DNA primers being represented by the sequences (i) - (xx) ; producing a second DNA fragment by repetitively combining said second pair of DNA primers with melted target DNA and incubating said combined DNA primers and target DNA with nucleotides and a DNA polymerase having proofreading ability to produce said second DNA fragment, said second DNA fragment being different than said first DNA fragment and also being complementary to said target DNA, said second DNA fragment being at least 2 Kb; restricting said first and second DNA fragments; and recombining the restricted portions of said first and second DNA fragments into a multimerized DNA, said multimerized DNA encoding spider silk protein and being at least 4 Kb.
16. The multimerization proceεs according to Claim 15, wherein all DNA primers are represented by sequences
(i) - (xxvi) .
17. The multimerization process according to Claim 16, wherein all DNA primers are different.
18. The multimerization process according to any of Claims 15-17, wherein said multimerized DNA is at least 6 Kb.
19. The multimerization process according to Claim 18, .-'ie-eiu said multimerized DNA is at least 8 Kb.
20. A process of producing silk protein, comprising the stepε of: selecting a DNA according to Claim 12, inserting said DNA into an expression vector; transfecting host cells with said expresεion vector;
- 56 -
fermenting said transfected host in culture media to produce silk protein; and recovering said silk protein.
21. The procesε according to Claim 20, wherein said culture media contains protease inhibitor.
22. The process of producing silk protein according to Claim 21, further comprising the steps of: applying ultrasound energy to rupture the host cells; applying ultrasound energy to resuspend silk protein; and centrifuging said ruptured host cells to separate cell membranes from said silk protein.
23. The process of producing silk protein according to Claim 22, further comprising the steps of purifying the silk protein by ultrafiltration or alcohol precipitation.
24. The process for spinning silk protein comprising the steps of concentrating silk protein purified according to Claim 23; drawing a fiber of concentrated silk protein; spinning silk fibers to produce a silk thread; and washing the silk thread to remove any solubilization reagents.
25. The process for spinning silk according to Claim 24, wherein the solubilization reagents are selected from the group consisting of sodium hydroxide, potassium hydroxide, hexafluoroisopropanol, guanidine hydrochloride, urea, urea phosphate, lithium salts, organic solvents, ammonium sulfate, acetic acid, phosphorit. acid, dichloroacetic aciα, formic acid and sulfuric acid.
26. The process for spinning silk according to Claim 24, further comprising the step of coating said silk fibers or threads with oxides of tin or titanium.
27. A fabric compriεing εilk threadε made according to Claim 24.
28. A fabric according to Claim 27, further comprising silkworm, Kevlar®, graphite or carbon fibers.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51769495A | 1995-08-22 | 1995-08-22 | |
US517694 | 1995-08-22 | ||
PCT/US1996/013767 WO1997008315A1 (en) | 1995-08-22 | 1996-08-22 | Cloning methods for high strength spider silk proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0848754A1 true EP0848754A1 (en) | 1998-06-24 |
Family
ID=24060849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96932937A Withdrawn EP0848754A1 (en) | 1995-08-22 | 1996-08-22 | Cloning methods for high strength spider silk proteins |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0848754A1 (en) |
JP (1) | JPH11511325A (en) |
CN (1) | CN1200145A (en) |
AU (1) | AU7152996A (en) |
BR (1) | BR9612625A (en) |
IL (1) | IL123398A0 (en) |
WO (1) | WO1997008315A1 (en) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2774588B1 (en) * | 1998-02-11 | 2000-05-05 | Oreal | COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING AT LEAST ONE NATURAL, RECOMBINANT ARACHNID SILK PROTEIN OR THE LIKE |
US7157615B2 (en) | 1998-03-17 | 2007-01-02 | Nexia Biotechnologies, Inc. | Production of biofilaments in transgenic animals |
EP1251888A1 (en) * | 2000-02-03 | 2002-10-30 | Nexia Biotechnologies, Inc. | Surgical sutures containing spider silk |
US6608242B1 (en) * | 2000-05-25 | 2003-08-19 | E. I. Du Pont De Nemours And Company | Production of silk-like proteins in plants |
CA2411600A1 (en) * | 2000-06-09 | 2001-12-13 | Ipk Institut Fur Pflanzenzengenetik Und Kulturplanzenforschung | Synthetic spider silk proteins and the expression thereof in transgenic plants |
US6642361B2 (en) * | 2000-06-29 | 2003-11-04 | Fiona F. Hunter | Isolated cocoon silk protein from Simulium vittatum and nucleic acids encoding such protein |
US20110009960A1 (en) | 2001-11-16 | 2011-01-13 | Allergan, Inc. | Prosthetic fabric structure |
GB2399820A (en) * | 2002-01-11 | 2004-09-29 | Nexia Biotech Inc | Recovery of biofilament proteins from biological fluids |
WO2004000915A2 (en) | 2002-06-24 | 2003-12-31 | Tufts University | Silk biomaterials and methods of use thereof |
EP2374919B9 (en) | 2003-03-11 | 2013-10-23 | Allergan, Inc. | Biocompatible repair strengthening silk fabric |
EP3231846A1 (en) | 2003-04-10 | 2017-10-18 | Tufts University | Concentrated aqueous silk fibroin solution and use thereof |
EP2395014A3 (en) * | 2005-10-05 | 2012-07-11 | Commonwealth Scientific and Industrial Research Organization | Silk proteins |
WO2007078239A2 (en) | 2005-12-30 | 2007-07-12 | Spiber Technologies Ab | Spider silk proteins and methods for producing spider silk proteins |
US20100028451A1 (en) | 2006-09-26 | 2010-02-04 | Trustees Of Tufts College | Silk microspheres for encapsulation and controlled release |
JP2010522583A (en) | 2007-02-27 | 2010-07-08 | トラスティーズ オブ タフツ カレッジ | Silk organs made by tissue engineering |
WO2009023615A1 (en) | 2007-08-10 | 2009-02-19 | Trustees Of Tufts College | Tubular silk compositions and methods of use thereof |
CA2713251A1 (en) * | 2008-02-07 | 2009-08-13 | Trustees Of Tufts College | 3-dimensional silk hydroxyapatite compositions |
KR20110094277A (en) | 2008-10-09 | 2011-08-23 | 트러스티즈 오브 터프츠 칼리지 | Modified silk films containing glycerol |
US9427499B2 (en) | 2008-11-17 | 2016-08-30 | Trustees Of Tufts College | Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials |
US9308070B2 (en) | 2008-12-15 | 2016-04-12 | Allergan, Inc. | Pliable silk medical device |
US20130245757A1 (en) | 2011-11-04 | 2013-09-19 | Allergan, Inc. | Method and device for improved soft tissue surgery |
US20120070427A1 (en) | 2009-06-01 | 2012-03-22 | Trustees Of Tufts College | Vortex-induced silk fibroin gelation for encapsulation and delivery |
JP2012533780A (en) | 2009-07-20 | 2012-12-27 | タフツ ユニバーシティー/トラスティーズ オブ タフツ カレッジ | Implantable absorptive reflector made of protein only |
NZ598691A (en) | 2009-09-11 | 2014-05-30 | Allergan Inc | Prosthetic device and method of manufacturing the same |
WO2011109691A2 (en) | 2010-03-05 | 2011-09-09 | Trustees Of Tufts College | Silk-based ionomeric compositions |
EP2559101B1 (en) | 2010-04-12 | 2016-02-24 | Tufts University | Silk electronic components |
SG10201607262PA (en) | 2010-08-30 | 2016-10-28 | Harvard College | A High Strength Chitin Composite Material and Method of Making |
CA2847590A1 (en) | 2010-09-03 | 2012-03-08 | Tufts University/Trustees Of Tufts College | Plasmonic nanoparticle-doped silk materials |
JP5691052B2 (en) * | 2010-09-10 | 2015-04-01 | 岡本株式会社 | Recombinant organisms and proteins made by recombinant organisms |
US9761789B2 (en) | 2010-09-27 | 2017-09-12 | Tufts University | Silk-based piezoelectric materials |
EP4218891A1 (en) | 2010-10-19 | 2023-08-02 | Trustees Of Tufts College | Silk fibroin-based microneedles and methods of making the same |
WO2012145652A1 (en) | 2011-04-20 | 2012-10-26 | Trustees Of Tufts College | Dynamic silk coatings for implantable devices |
EP2699266B1 (en) | 2011-04-21 | 2019-06-12 | Trustees Of Tufts College | Compositions and methods for stabilization of active agents |
WO2013070907A1 (en) | 2011-11-08 | 2013-05-16 | Tufts University | A silk-based scaffold platform for engineering tissue constructs |
AU2012335122B2 (en) | 2011-11-09 | 2016-09-22 | Trustees Of Tufts College | Injectable silk fibroin foams and uses thereof |
US9931434B2 (en) | 2011-11-09 | 2018-04-03 | Trustees Of Tufts College | Injectable silk fibroin particles and uses thereof |
US10126467B2 (en) | 2011-12-05 | 2018-11-13 | Tufts University | Signal enhancement by silk photonic crystals |
US20150010630A1 (en) | 2011-12-29 | 2015-01-08 | Trustees Of Tufts College | Functionalization of biomaterials to control regeneration and inflammation responses |
ES2856873T3 (en) | 2012-02-06 | 2021-09-28 | Childrens Medical Center | Multilayer biomaterial for tissue regeneration and wound healing |
NL1039495C2 (en) * | 2012-03-27 | 2013-09-30 | Jalila Essaidi | METHOD FOR MANUFACTURING A SKIN SUBSTITUTE BASED ON SPIDER SIDE AND WEAR STRUCTURE MANUFACTURED USING THIS METHOD AND WEAR STRUCTURE WITH GROWING LIVING SKIN. |
EP2836236B1 (en) | 2012-04-13 | 2019-01-02 | Trustees Of Tufts College | Methods and compositions for preparing a silk microsphere |
US10653786B2 (en) | 2012-04-25 | 2020-05-19 | Trustees Of Tufts College | Silk microspheres and methods for surface lubrication |
US10034945B2 (en) | 2012-07-13 | 2018-07-31 | Trustees Of Tufts College | Silk powder compaction for production of constructs with high mechanical strength and stiffness |
WO2014035798A1 (en) | 2012-08-30 | 2014-03-06 | Sanofi | Silk lyogels for sustained release of protein therapeutics and methods of making and uses |
US10035920B2 (en) | 2012-11-27 | 2018-07-31 | Tufts University | Biopolymer-based inks and use thereof |
JP6457482B2 (en) | 2013-03-15 | 2019-01-23 | トラスティーズ オブ タフツ カレッジ | Low molecular weight silk composition and stabilization of silk composition |
WO2014144971A1 (en) | 2013-03-15 | 2014-09-18 | Tufts University | Silk water lithography |
US11376329B2 (en) | 2013-03-15 | 2022-07-05 | Trustees Of Tufts College | Low molecular weight silk compositions and stabilizing silk compositions |
US11009792B2 (en) | 2013-03-15 | 2021-05-18 | Tufts University | All water-based nanopatterning |
CA2905365C (en) | 2013-03-15 | 2021-03-23 | Banner Life Sciences Llc | Silk-based capsules |
CN103194068B (en) * | 2013-04-08 | 2015-12-23 | 浙江大学 | A kind of method of stable silk fibroin protein solution |
WO2014176458A2 (en) | 2013-04-24 | 2014-10-30 | Trustees Of Tufts College | Bioresorbable biopolymer anastomosis devices |
WO2015054125A1 (en) | 2013-10-08 | 2015-04-16 | Trustees Of Tufts College | Tunable covalently crosslinked hydrogels and methods of making the same |
WO2015070108A1 (en) | 2013-11-08 | 2015-05-14 | Tufts University | Peptide-based nanofibrillar materials |
MA39720A (en) | 2014-03-07 | 2017-01-11 | Univ Tufts | Biopolymer-based preservation of perishable products |
EP3147369A4 (en) | 2014-05-21 | 2018-02-07 | Ajinomoto Co., Inc. | Fibroin-like protein production method |
WO2016028797A1 (en) | 2014-08-18 | 2016-02-25 | Allergan, Inc. | Pliable silk medical device |
WO2016100721A1 (en) | 2014-12-17 | 2016-06-23 | Tufts University | Injectable, flexible hydroxyapatite-silk foams for osteochondral and dental repair |
WO2016145281A1 (en) | 2015-03-12 | 2016-09-15 | Tufts University | Shape memory silk materials |
US20200078495A1 (en) | 2015-07-20 | 2020-03-12 | Tufts University | Biodegradable silk ear tubes |
CN105231565B (en) * | 2015-10-20 | 2018-01-16 | 杭州华水布艺有限公司 | A kind of anti-stab protective fabric containing ice-cold material |
WO2017123383A2 (en) | 2015-12-17 | 2017-07-20 | Trustees Of Tufts College | Silk-fibroin hydrogels, methods of forming, and uses thereof |
US20190001272A1 (en) | 2015-12-18 | 2019-01-03 | Tufts University | Silk Solution Purification System, Concentrating System, and Methods Thereof |
US11643444B2 (en) | 2016-05-04 | 2023-05-09 | Trustees Of Tufts College | Silk nanofibrils and uses thereof |
US11298443B2 (en) | 2016-07-01 | 2022-04-12 | Trustees Of Tufts College | Innervated artificial skin |
US11248313B2 (en) | 2016-08-01 | 2022-02-15 | Trustees Of Tufts College | Biomimetic mechanical tension driven fabrication of nanofibrillar architecture |
CA3037337A1 (en) | 2016-09-19 | 2018-03-22 | Vaxess Technologies, Inc. | Vaccine formulations with increased stability |
US11247181B2 (en) | 2016-10-24 | 2022-02-15 | Trustees Of Tufts College | Biomimetic multilayer compositions |
WO2018081805A1 (en) | 2016-10-31 | 2018-05-03 | Sofregen Medical, Inc. | Compositions comprising low molecular weight silk fibroin fragments and plasticizers |
US20200000713A1 (en) | 2017-01-20 | 2020-01-02 | Massachusetts Institute Of Technology | Injectable polymer micro-depots for controlled local drug delivery |
WO2019067737A1 (en) * | 2017-09-27 | 2019-04-04 | Silk, Inc. | Materials comprising recombinant silk and methods of preparing the same |
US11419947B2 (en) | 2017-10-30 | 2022-08-23 | Massachusetts Institute Of Technology | Layer-by-layer nanoparticles for cytokine therapy in cancer treatment |
WO2019195350A1 (en) | 2018-04-03 | 2019-10-10 | Vaxess Technologies, Inc. | Microneedle comprising silk fibroin applied to a dissolvable base |
EP3830576A2 (en) | 2018-07-27 | 2021-06-09 | Vaxess Technologies, Inc. | Polymer-based biospecimen collection devices and uses thereof |
WO2020112742A1 (en) * | 2018-11-28 | 2020-06-04 | Bolt Threads, Inc. | Alkaline purification of spider silk proteins |
CN110106571A (en) * | 2019-04-09 | 2019-08-09 | 商文辉 | A kind of spider web textile fabric and preparation method thereof |
WO2021076798A1 (en) | 2019-10-15 | 2021-04-22 | Sofregen Medical, Inc. | Delivery devices for delivering and methods of delivering compositions |
WO2024073169A1 (en) | 2022-09-26 | 2024-04-04 | Massachusetts Institute Of Technology | Integrating biopolymer design with physical unclonable functions for anticounterfeiting and product traceability |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7691191A (en) * | 1990-04-19 | 1991-11-11 | United States Of America, As Represented By The Secretary Of The Army, The | Recombinant spider silk proteins through genetic engineering |
DE69131969T2 (en) * | 1990-04-20 | 2000-06-15 | Univ Wyoming Laramie | DNA encoding spider silk protein, vector containing DNA, transformed cell and products thereof |
-
1996
- 1996-08-22 AU AU71529/96A patent/AU7152996A/en not_active Abandoned
- 1996-08-22 EP EP96932937A patent/EP0848754A1/en not_active Withdrawn
- 1996-08-22 CN CN96197771.XA patent/CN1200145A/en active Pending
- 1996-08-22 WO PCT/US1996/013767 patent/WO1997008315A1/en not_active Application Discontinuation
- 1996-08-22 JP JP9510520A patent/JPH11511325A/en active Pending
- 1996-08-22 IL IL12339896A patent/IL123398A0/en unknown
- 1996-08-22 BR BR9612625A patent/BR9612625A/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO9708315A1 * |
Also Published As
Publication number | Publication date |
---|---|
IL123398A0 (en) | 1998-09-24 |
WO1997008315A1 (en) | 1997-03-06 |
CN1200145A (en) | 1998-11-25 |
JPH11511325A (en) | 1999-10-05 |
BR9612625A (en) | 1999-06-01 |
AU7152996A (en) | 1997-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0848754A1 (en) | Cloning methods for high strength spider silk proteins | |
DE69433299T2 (en) | RECOMBINANT SPIDER SILK ANALOG | |
US5245012A (en) | Method to achieve solubilization of spider silk proteins | |
JP6556122B2 (en) | Methods and compositions for synthesizing improved silk fibers | |
Boman et al. | Cell-free immunity in Cecropia: a model system for antibacterial proteins | |
AU2006299740B2 (en) | Silk proteins | |
US5728810A (en) | Spider silk protein | |
Fedic et al. | The silk of Lepidoptera | |
Matsumoto et al. | Molecular cloning of a cDNA and assignment of the C-terminal of sarcotoxin IA, a potent antibacterial protein of Sarcophaga peregrina | |
DE3752363T2 (en) | PREPARATION OF SYNTHETIC DNA AND THEIR USE IN THE SYNTHESIS OF LARGE POLYPEPTIDES | |
DE60128914T2 (en) | Antibodies of human origin to inhibit platelet aggregation | |
DE69133317T2 (en) | Structural proteins through artificial genes | |
DE3111592A1 (en) | "E. COLI STRUCTURED BOWL GROWTH HORMONE (RWH) APPROVED AND THEIR USE FOR THE PRODUCTION OF RWH" | |
WO1988007576A2 (en) | VASCULAR ANTICOAGULANT PROTEINS, DNAs WHICH CODE FOR THEM, MANUFACTURE AND APPLICATION THEREOF | |
DE60023860T2 (en) | PROCESS FOR THE PRODUCTION OF RECOMBINANT PEPTIDES | |
DE69535358T2 (en) | HEMOPHILUS INFLUENZAE ADHERENCE AND PENATRATION PROTEINS | |
DE19532001A1 (en) | New antibacterial peptide, moricin, from silkworms | |
DE69735207T2 (en) | NOVEL, FIBRINOGENIC BINDING PROTEIN, DERIVED FROM A COAGULASE NEGATIVE STAPHYLOKOKKUS | |
CN109797155A (en) | Portunus trituberculatus Miers mannose binding lectin PtMBL gene and its coding albumen and application | |
EP0452925B1 (en) | Isolated DNA coding for spider silk protein, a replicable vector and a transformed cell containing the isolated DNA, and products thereof | |
JP2001510022A (en) | Toxin genes from the bacteria Xenorabodos nematofilus and Photolabdos luminescence | |
US8461301B2 (en) | Synthetic dragline spider silk-like proteins | |
WO1991016351A1 (en) | Recombinant spider silk proteins through genetic engineering | |
DE60124921T2 (en) | GENES WHICH CODE LUCIFERIN REGENERATING PROTEINS, RECOMBINANT DNA, AND METHOD FOR THE PRODUCTION OF A LUCIFERIN REGENERATING PROTEIN | |
CA2361534C (en) | Alpha-conotoxin peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980220 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19990302 |